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HealthAbstract Annona muricata L. (Magnoliales: Annonaceae) is a tropical plant species known for its
edible fruit which has some medicinal merits, but also some toxicological effects. This review
focuses on the phytochemicals contents, bioactivity, biological actions and toxicological aspects
of extracts and isolated compounds, as well as medicinal uses of A. muricata, with the objective
of stimulating further studies on extracts and fruit pulp used for human consumption. Traditional
medicinal uses of A. muricata have been identiﬁed in tropical regions to treat diverse ailments such
as fever, pain, respiratory and skin illness, internal and external parasites, bacterial infections,
hypertension, inﬂammation, diabetes and cancer. More than 200 chemical compounds have been
identiﬁed and isolated from this plant; the most important being alkaloids, phenols and
acetogenins. Using in vitro studies, extracts and phytochemicals of A. muricata have been
characterized as an antimicrobial, anti-inﬂammatory, anti-protozoan, antioxidant, insecticide,Yahia),
armaco-
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logical activities, mechanisms of action andlarvicide, and cytotoxic to tumor cells. In vivo studies of the crude extracts and isolated compounds
of A. muricata were shown to possess anxiolytic, anti-stress, anti-inﬂammatory, contraceptive, anti-
tumoral, antiulceric, wound healing, hepato-protective, anti-icteric and hypoglycemic activities. In
addition, clinical studies support the hypoglycemic activity of the ethanolic extracts of A. muricata
leaves. Mechanisms of action of some pharmacological activities have been elucidated, such as cyto-
toxic, antioxidant, antimicrobial, antinociception and hypotensive activities. However, some phyto-
chemical compounds isolated from A. muricata have shown a neurotoxic effect in vitro and in vivo,
and therefore, these crude extracts and isolated compounds need to be further investigated to deﬁne
the magnitude of the effects, optimal dosage, mechanisms of action, long-term safety, and potential
side effects. Additionally, clinical studies are necessary to support the therapeutic potential of this
plant.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Medicinal plants are considered as the basis for health preservation
and care worldwide. Chronic degenerative diseases (diabetes, cardio-
vascular and cancer) have reached epidemic proportions and are con-
sidered as a serious health problem; therefore, the treatments of these
diseases are of clinical importance (WHO, 2005). Annona muricata L. is
a species of the Annonaceae family that has been widely studied in the
last decades due to its therapeutic potential. The medicinal uses of the
Annonaceae family were reported long time ago (Billo´n, 1869), andz, A.V. et al., Annona muricata: A com
toxicityAnnona muricata –>. Arabian Jsince then, this species has attracted the attention due to its bioactivity
and toxicity.
Ethnobotanical studies have indicated that A. muricata has been
used as insecticide (Leatemia and Isman, 2004) and parasiticide
(Langenberger et al., 2009). Fruit juice and infusions of leaves or
branches have been used to treat fever (Betancur-Galvis et al., 1999;
Dagar and Dagar, 1991; Magan˜a et al., 2010), sedative (Deﬁlippis
et al., 2004; Joyeux et al., 1995), respiratory illness (Beyra et al.,
2004; Kossouoh et al., 2007; Vandebroek et al., 2010; Waizel and
Waizel, 2009), malaria (Boyom et al., 2011; Nguyen-Pouplin et al.,prehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
ournal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.004
Annona muricata 32007), gastrointestinal problems (Atawodi, 2011; Magan˜a et al., 2010;
Samuel et al., 2010), liver, heart and kidney affections (Badrie and
Schauss, 2009; Coe, 2008). In recent years it has become widely used
for hypoglycemic (De Souza et al., 2011; Rodrı´guez, 2011), hypoten-
sive (De Souza et al., 2011; Hajdu and Hohmann, 2012; Samuel
et al., 2010) and cancer treatments (Monigatti et al., 2013; Tisott
et al., 2013).
Some publications and reviews about A. muricata have been con-
ducted to integrate the available scientiﬁc studies on this plant with
special interest on acetogenins as principal bioactive compounds
(Badrie and Schauss, 2009; Moghadamtousi et al., 2015a; Pinto
et al., 2005) Other bioactive compounds have been identiﬁed, more
bioactivities have been evaluated, and medicinal uses have been
extended. The aim of this review was to integrate the scientiﬁc studies
reported until 2015 that describe the traditional medicinal uses and
phytochemical contents of A. muricata, and relate them with the phar-
macological and its mechanisms of action and toxicological evaluation.
The bioactivity tested can be the base for therapeutic utilization, but
the toxicological research results are important to consider the thera-
peutical uses of this plant versus its toxicity, and the potential harmful
effects of products prepared from this plant.
2. Botany and traditional uses
2.1. Botany
A. muricata is known as soursop (English), graviola (Por-
tuguese), guana´bana (Latin American Spanish) and other local
indigenous names listed in Table 1. This plant is species of the
genus Annona, of the Annonaceae family, order Magnoliales
and Division Magnoliophyta (Pinto et al., 2005). The genus
Annona comprises over 70 species among which A. muricata
is the most widely grown. Its synonyms are A. bonplandiana
Kunth; A. cearensis Barb. Rodr., A. macrocarpa Werckle´; A.
muricata var. borinquensis Morales and Guanabanus muricatus
M. Go´mez (Pinto et al., 2005).
The soursop tree is about 5–10 m tall and 15–83 cm in
diameter with low branches (Benavides, 2003; Evangelista-
Lozano et al., 2003; Orwa et al., 2009). It tends to bloom
and fruit most of the year, but there are more deﬁned seasons
depending on the altitude (Pinto et al., 2005). It is distributed
in the tropical regions of Central and South America, Western
Africa and Southeast Asia (Pinto et al., 2005), at altitudes
below 1200 m above sea level, with temperatures between 25
and 28 C, relative humidity between 60 and 80%, and annual
rainfall above 1500 mm. The soursop fruit is an edible collec-
tive ovoid berry, dark green in color. Its average weight is
4 kg in some countries (Pinto et al., 2005), but in Me´xico
(Evangelista-Lozano et al., 2003), Venezuela (Ojeda et al.,
2007) and Nicaragua (Benavides, 2003), it ranges between
0.4 and 1.0 kg. Each fruit may contain 55–170 black seeds
(Awan et al., 1980) when fresh and they turn light brown when
dry. The ﬂesh is white and creamy with a characteristic aroma
and ﬂavor (Pinto et al., 2005).
2.2. Traditional medicinal uses
The leaves, bark, fruit and seed of A. muricata have been sub-
ject of countless medicinal uses (Badrie and Schauss, 2009;
Billo´n, 1869). Table 1 enlists the traditional medicinal uses that
have been reported for this species, as well as the places in
which they are used. The most widely used preparation in tra-
ditional medicine is the decoction of bark, root, seed or leafPlease cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
logical activities, mechanisms of action and toxicityAnnona muricata –>. Arabian Jand applications are varied. In Indonesia, the Caribbean
islands (Boulogne et al., 2011) and South Paciﬁc countries,
the leaves are used in bath (Longuefosse and Nossin, 1996)
to treat skin ailments, while in Mauritius (Sreekeesoon and
Mahomoodally, 2014), New Guinea (WHO, 2009) and Ecua-
dor (Tene et al., 2007), the application of leaves is local on
the pain site. The ingestion of leaves decoction is used as anal-
gesic in Brazil (Ross, 2010), Martinique (Longuefosse and
Nossin, 1996), Mexico and Nicaragua (Ross, 2010), while in
several countries such as Benin (Kossouoh et al., 2007), the
Caribbean (Joyeux et al., 1995), Cuba (Beyra et al., 2004)
and Me´xico (Waizel and Waizel, 2009), it is used to treat dis-
comfort associated with colds, ﬂu and asthma. Natives of
Malaysia used A. muricata leaves to treat cutaneous (external)
and internal parasites (Badrie and Schauss, 2009). The use of
leaves to treat malaria is very important in tropical countries
as Cameroon, Togo, and Vietnam (Boyom et al., 2011;
Nguyen-Pouplin et al., 2007; Ross, 2010). In Ghana, A. muri-
cata and some other plants are decocted into a mixture and
used in bath where females sit in (Asase et al., 2012).
The fruit is not only appreciated as food, but the juice is
used as galactogogue to treat diarrhea, heart and liver diseases
(Badrie and Schauss, 2009; Hajdu and Hohmann, 2012), and
against intestinal parasites in South America (Badrie and
Schauss, 2009). Lately, the medicinal uses of A. muricata leaves
included treatments for hypertension (Badrie and Schauss,
2009; Ezuruike and Prieto, 2014; Hajdu and Hohmann,
2012; Mootoosamy and Fawzi, 2014; TDRG, 2002), diabetes
(Badrie and Schauss, 2009; De Souza et al., 2011; Ezuruike
and Prieto, 2014) and cancer (Alonso-Castro et al., 2011;
Atawodi, 2011; Bussmann et al., 2010; Monigatti et al.,
2013). Some patients used decoctions or capsules of A. muri-
cata for cancer and pharmacological treatments (Tisott et al.,
2013).
Unripe fruit, seeds, leaves and roots are also used as biopes-
ticides, bioinsecticides and topical insect repellents (Brechelt,
2004; Isman and Akhtar, 2007; Leatemia and Isman, 2004).
The importance of this species in pest control was indicated
in the edition of ‘‘Pesticide action and alternatives for Latin
America”, which recommended the use of aqueous extract of
A. muricata to control lepidopteran larvae, aphids and thrips,
among others (Brechelt, 2004).
3. Phytochemicals
Two hundred and twelve bioactive compounds have been
reported to be found in A. muricata. The predominant com-
pounds are acetogenins followed by alkaloids, phenols and
other compounds. Leaves and seeds are the main plant organs
studied, probably because they are the most traditionally used.
Table 2 lists the bioactive compounds, and their structures are
shown in Figs. 1–4. The majority of phytochemicals have been
identiﬁed from organic extract, but recently focus has also
been directed toward aqueous extracts. Several other com-
pounds such as carbohydrates and essential oils have also been
reported, but these are not considered in this review.
3.1. Alkaloids
Alkaloids are naturally occurring compounds containing basic
nitrogen atoms. The most abundant in A. muricata (Table 2)prehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
ournal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.004
Table 1 A. muricata: local names, medicinal uses, plant part used, and type of preparations.
Country or
region
Local name Medicinal uses Plant part Preparation/application References
Benin Araticum, araticum-do-grande condessa;
graviola;
jaca-do-para; jaca-de-pobre; fruta-do
conde,
cameroon, soursop
Insomnia, catarrh, febrifuge Leaf
Bark
Root
Seed
Decoction/oral Kossouoh et al. (2007)
Bolivia Sinini Kidney disorders, hypertension Fruit
Leaf
Juice/oral
Decoction/oral
Hajdu and Hohmann (2012)
Brazil Araticum, araticum-do-grande, corac¸a˜o-
da-rainha, condessa; graviola;
jaca-do-para´; jaca-de-pobre; fruta-do
conde,
cameroon, Soursop
Snake bite
Analgesic
Leaf Macerate/topical
Decoction/oral
Ritter et al. (2012) and Ross (2010)
Lactagogue, astringent, diarrhea, dysentery Fruit Juice/oral Badrie and Schauss (2009) and
Cercato et al. (2015)Arthritis pain, rheumatism, neuralgia, weight loss Leaf Decoction/oral
Cameroon Soursop, Sabasaba
Ebom beti
Malaria, anthelmintic, parasites, antimicrobial,
anticonvulsant, digestive
Typhoid fever
Leaf Decoction/oral Boyom et al. (2011), Tsabang et al.
(2012)
Roger et al. (2015)
Caribbean Graviola, Jamaica soursop, prickly
custard apple, soursop
Chills, febrifuge, ﬂu, indigestion, nervousness,
palpitations, rash, spasms, skin disease, sedative
Leaf
Bark
NR Joyeux et al. (1995), TDRG (2002),
and Boulogne et al. (2011)
Colombia Guana´bana Febrifuge, inﬂammation Fruit,
Leaf
Juice/oral
Decoction/oral
Betancur-Galvis et al. (1999)
Diarrhea, abortifacient, lactagogue NR NR Go´mez-Estrada et al. (2011)
Cuba Guana´bana Catarrh Leaf Decoction in milk or
water/oral
Beyra et al. (2004)
Dominican
Republic
Guana´bana Respiratory conditions, women in labor
Galactogogue
Leaf
Fruit
NR
Infusion/oral
Vandebroek et al. (2010) and Ross
(2010)
Plague Seed NR Brechelt (2004)
Ecuador Guana´bana Rheumatism Leaf Heated/topical Tene et al. (2007)
Ghana Apre Malaria Root Decoction/bath Asase et al. (2012)
Guyana Cachiman, corossol, Money Apple,
soursop, sorasaka, kaiedi, zuurzak,
soensaka, sroesaka, soeng sakka, sun-
saka, corossolier
Sedative, cardiotonic
Convulsion
Stem
Leaf
Seed
Infusion/oral
Infusion/oral
NR
Deﬁlippis et al. (2004) and TDRG
(2002)
Haiti Guana´bana, korosol Flu, heart aﬀectation parasite, pellagra, anxiety,
febrifuge, diarrhea, lactagogue
Leaf
Fruit
NR Badrie and Schauss (2009)
India Mamphal, Fo´fı´, Suppurative, febrifuge
Pain and pus from ulcers
Leaf Decoction/oral
Smeared in coconut
oil/topical
Dagar and Dagar (1991)
Tonic Bark NR Badrie and Schauss (2009)
Spasms, parasites Root
Bechic Flower
Insecticidal, astringent, ﬁsh-poison Seed
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Table 1 (continued)
Country or
region
Local name Medicinal uses Plant part Preparation/application References
Indonesia Sirsak; nangka belanda; nangka seberang;
Zuurzak
Wulanda
Insecticidal
Dermatitis
Malaria
Leaf and
other tree
parts
Leaf
NR
Pounding
Leatemia and Isman (2004), Badrie
and Schauss (2009)
Roosita et al. (2008)
Abdillah et al. (2015)
Jamaica Jamaica soursop Spasms, anxiety, asthenia, asthma, heart aﬀections,
febrifuge, parasites, diarrhea, lactagogue, dewormer,
dysentery, pain, diuretic
Branch
Leaf
Fruit
Decoction/oral Asprey and Thornton (1955) and
Badrie and Schauss (2009)
Madagascar Corossol Heart palpitation, malaria, liver maladies Leaf Decoction Novy (1997)
Malaysia Durian belanda, durian blanda, durian,
benggala, durian maki, durian makkah,
seri kaya belanda
Lice Leaf Crushed/topical Badrie and Schauss (2009)
Stomach pain, hypertension Fruit Juice/oral Samuel et al. (2010)
Martinique Kowosol Skin rashes, sedative Thoracic pain, inﬂammation,
ﬂatulence, liver disease
Leaf Crushed/Bath
Decoction/oral
Longuefosse and Nossin (1996)
Mauritius Corossol
Corossol
Hypertension
Headache
Leaf Infusion/oral
Crushed/topical
Mootoosamy and Fawzi (2014) and
Sreekeesoon and Mahomoodally
(2014)
Mexico Takole, pobox, ajpox Cabeza de negro;
catuch, chincua,
guana´bana; guana´bano;
polvox; tak´ob; tak´op caduts-at; xun´apill;
llama de tehuantepec; zopote de viejas,
zapote agrio. Anona, tzon te chkia nion
Dysentery, diabetes
Gastric cancer, gastrointestinal disorders, stomach
pain
Fruit
Leaf
Juice/oral
Decoction/oral
Alonso-Castro et al. (2011)
Febrifuge, diarrhea, dysentery, stomach pain Young
leaf
Infusion/oral Magan˜a et al. (2010) and Yasunaka
et al. (2005)
Bronchitis, asthma, leprae Leaf, stem Infusion/oral Waizel and Waizel (2009)
Nicaragua Guana´bana, pumo, puntar waithia,
saput, sarifa, seremaia, soursap
Ringworm
Abdominal and back pain, menstrual hemorrhage,
abortions, fever, vaginal infection
Renal and skin disorders, diarrhea
Insecticidal
Leaf
Seed
Plaster/topical
Infusion/oral
Decoction/oral
Benavides (2003) and Ross (2010), Coe
(2008)
Nigeria Soursop, graviola,
pawpaw brasilen˜a, Abo, Chop-chop, Sapi
sapi
Gastric disorders, Prostate cancer, diabetes, neuralgia,
rheumatism, arthritic pain
Leaf
Unripe
fruit
Decoction/oral
Juice/oral
Pinto et al. (2005), Atawodi (2011),
and Ezuruike and Prieto (2014)
Panama Guana´bana Dyspepsia, allergy, helminthiasis
Diarrhea
Stomach ulcer
Leaf
Bark
Pulp
NR
Decoction/oral
Gupta et al. (1979) and Ross (2010)
(continued on next page)
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Table 1 (continued)
Country or
region
Local name Medicinal uses Plant part Preparation/application References
Philippines Babana
Babana´, guyabano, gwabana
Lice, dandruﬀ
Cancer, ascariasis, high blood pressure, stomach
acidity, urination diﬃculty, cough
Headache
Diabetes
Leaf
Leaf
Fruit
NR
Decoction/oral
Poultice/topical
Pulp/oral
Badrie and Schauss (2009) and
Langenberger et al. (2009)
Ong and Kim (2014)
New
Guinea
Saua sap
Sow sop
Kahiloko
Stomach pain Leaf Heated/compression Badrie and Schauss (2009) and WHO
(2009)
Peru Guana´bano, guana´bana, cashacushma Obesity, gastritis, dyspepsia, diabetes, inﬂammation,
cancer, spasms, sedative, ﬂu, febrifuge, anxiety,
kidneys, prostate, urinary tract, infection,
inﬂammation, panacea
Fruit,
Leaf
Pulp, juice/oral
Infusion/oral
Badrie and Schauss (2009), Bussmann
et al. (2010), Rodrı´guez (2011), Poma
et al. (2011), and Monigatti et al.
(2013)
South
paciﬁc
countries
Durian belanda, soursop, seremaia,
sarifa, apele, katara ara tara
Stomach ailments, indigestio´n
Skin diseases
Dizziness, fainting spells
Leaf
Leaf
Infusion/oral
Bath
Inhaled
WHO (1998)
Ross (2010)
Thailand Thu-rian-khack, thurian-thet, thurian
khaek
Insecticidal Seed NR Badrie and Schauss (2009)
Trinidad y
Tobago
Soursop Hypertension Leaf NR Badrie and Schauss (2009), Lans
(2006)
Togo Anyigli, apele Hypertension, diabetes
Malaria
Leaf Decoction/oral De Souza et al. (2011) Ross (2010)
Uganda Ekitafeli Diabetes Leaf
Fruit
Infusion/oral
Pulp/oral
Ssenyange et al. (2015)
Vanuatu Soursop
Karasol, korosol, saosop
Scabies Leaf Infusion/Bath Bradacs et al. (2011)
Venezuela Catoche, catuche Liver aﬀectation, stomach pain, insecticidal Leaf
Seed
Decoction/oral
Crushed/topical
TDRG (2002) and Badrie and Schauss
(2009)
West Africa Dukume´ porto, niom, pinha, sawa sap,
alukuntum,
Sedative, nasopharyngeal aﬀectation
Diarrhea, dysentery, vermifuge, antidote
Leaf
Seed, bark
root
Decoction/oral Burkill (1985)
West Indies Apple leaf, kowoso, soursopl Asthmas, diarrhea, hypertension, parasites,
lactagogue, sedative
Skin ailments
Galactogogue
Leaf
Fruit
Decoction/oral
Decoction/bath
Poultice/oral
Feng et al. (1962), TDRG (2002), Ross
(2010), and Boulogne et al. (2011)
Vietnam
South
Ma˜ng caˆu xieˆm Malaria Leaf Infusion/oral Nguyen-Pouplin et al. (2007)
NR, Not reported.
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Table 2 Bioactive compounds isolated from A. muricata.
No Chemical name Part of
plant
Type Bioactivity References
Alkaloids
1 Anonaine Fruit
Leaf
Aporphine Antidepressive
Anti-plasmodium,
Dopamine
inhibitor
Cytotoxic
Hasrat et al. (1997a, 1997b),
Fofana et al. (2011), Ocampo and
Ocampo (2006), and Matsushige
et al. (2012)
2 Annonamine Leaf Aporphine Cytotoxic Matsushige et al. (2012)
3 Anomuricine Root
Bark
Isoquinoline NR Leboeuf et al. (1981)
4 Anomurine Root
Bark
Isoquinoline NR Leboeuf et al. (1981)
5 Asimilobine Fruit
Leaf
Aporphine Antidepressive
Cytotoxic
Hasrat et al. (1997a, 1997b) and
Fofana et al. (2012)
6 Atherospermine Stem Aporphine NR Leboeuf et al. (1981)
7 Atherosperminine Root
Bark
Aporphine NR Leboeuf et al. (1981)
9 Casuarine Leaf/stem Imino sugar NR Mohanty et al. (2008)
10 Coclaurine Root
Bark
Leaf
Isoquinoline NR Leboeuf et al. (1981) and Fofana
et al. (2012)
11 Coreximine Root
Bark
Leaf
Protoberberine Neurotoxic Leboeuf et al. (1981) and
Lannuzel et al. (2002)
12 DMDP (2,5-
Dihydroxymethyl-3,4,
dihydroxypyrrolidine)
Leaf/stem Imino sugar NR Mohanty et al. (2008)
13 DMJ (Deoxymannojirimycin) Leaf/stem Imino sugar NR Mohanty et al. (2008)
14 DNJ (Deoxynojirmycin) Leaf/stem Imino sugar NR Mohanty et al. (2008)
15 (R)-O,O-dimethylcoclaurine Leaf Isoquinoline Cytotoxic Matsushige et al. (2012)
16 Isoboldine Leaf Aporphine Antimalarial Fofana et al. (2012)
17 Isolaureline Leaf Aporphine Cytotoxic Fofana et al. (2011)
18 Liriodenine Leaf Aporphine NR Fofana et al. (2012)
19 (R)-4´O-methylcocaurine Leaf Isoquinoline Cytotoxic Matsushige et al. (2012)
20 N-methylcoclaurine Leaf Isoquinoline NR Fofana et al. (2012)
21 N-methylcoculaurine Leaf
Pulp
Isoquinoline NR Kotake et al. (2004)
22 Muricine Bark Isoquinoline NR TDRG (2002)
23 Muricinine Bark Isoquinoline NR TDRG, 2002
24 (S)-Narcorydine Leaf Aporphine Cytotoxic Matsushige et al. (2012)
25 Nornuciferine Fruit Isoquinoline Antidepressive/
in vitro NIH-3T3
Hasrat et al. (1997a, 1997b)
26 Remerine Leaf Isoquinoline NR Fofana et al. (2012)
27 Reticuline Stem
Leaf
Pulp
Isoquinoline Neurotoxic TDRG (2002) Leboeuf et al.
(1981), Lannuzel et al. (2002),
and Kotake et al. (2004)
28 Stepharine Leaf Isoquinoline NR Leboeuf et al. (1981)
29 Swainsonine Leaf/stem Imino sugar Stimulate immune
response
Mohanty et al. (2008)
30 Xylopine Leaf Isoquinoline NR Fofana et al. (2011)
Acetogenins
31, 32 Cohibin A, B Root
Seed
Linear, unsaturated, 2OH NR Alali et al. (1999) and Gleye et al.
(2000b)
33, 34 Cohibin C, D Seed Linear, unsaturated, 2OH NR Gleye et al. (2000b)
35 Donhexocin Seed Linear, 6OH NR Yu et al. (1997)
36 Montecristin Root
Pulp
Nectar
Linear, unsaturated, 2OH NR Alali et al. (1999) and Champy
et al. (2009)
37 Muricatenol Seed Linear, unsaturated, 4OH NR Li et al. (2000)
38 Murihexol Seed Linear, 6OH NR Yu et al. (1997)
39 Coronin Root NR TDRG (2002)
(continued on next page)
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Table 2 (continued)
No Chemical name Part of
plant
Type Bioactivity References
40, 41 Epomuricenins A, B or
epoxymurin
Seed
Root
Pulp
Mono epoxy unsaturated NR Zafra-Polo et al. (1996) and
Melot et al. (2009)
42, 43 Epomurinins A, B Pulp Mono epoxy NR Melot et al. (2009)
44, 45 Epomusenins A B Pulp Mono epoxy unsaturated NR Melot et al. (2009)
46 Epoxyrollin-
A = Dieporeticanin-1
Mono epoxy NR Zafra-Polo et al. (1996)
47 Murin A Stem Mono epoxy NR TDRG (2002)
48 Rolin B Seed Mono epoxy NR TDRG (2002)
49 Sabadelin Root
Pulp
Mono epoxy, 1 carbonyl Cytotoxic Gleye et al. (1999)
Ragasa et al. (2012)
50 Corepoxylone Seed Diepoxy, 1 carbonyl NR Gromek et al. (1993)
51, 52 Diepomuricanin A,
B = Epoxyrollin B
Seed Diepoxy NR Zafra-Polo et al. (1996)
53 Annocatalin Leaf Mono THF, 4OH Cytotoxic Liaw et al. (2002)
54 Annoglaxin Seed Mono THF 4OH, 1
carbonyl
NR Yang et al. (2010)
55 Annohexocin Leaf Mono THF, 6OH Cytotoxic Zeng et al. (1996)
56 Annomontacin Seed
Leaf
Mono THF, 4OH Cytotoxic
Insecticidal
Liaw et al. (2002), Nakanishi
et al. (2003), and Castillo-
Sa´nchez et al. (2010)
57 Annomontacin, cis Seed Mono THF, 4OH Cytotoxic Liaw et al. (2002) and Nakanishi
et al. (2003)
58 Annomuricin Leaf Mono THF,
5OH
Cytotoxic Kim et al. (1998b)
59 Annomuricin A Leaf
Peric
Mono THF, 5OH Cytotoxic Wu et al. (1995a) and Jaramillo
et al. (2000)
60 Annomuricin B Leaf Mono THF, 5OH Cytotoxic Wu et al. (1995a)
61, 62 Annomuricin C, E Leaf Mono THF, 5OH Cytotoxic Zeng et al. (1996) and
Moghadamtousi et al. (2015c)
63, 64 Cis, trans, Annomuricin-D-
one
Leaf Mono THF, 4OH Cytotoxic Alali et al. (1999)
65 Annomutacin Leaf Mono THF, 4OH Cytotoxic Wu et al. (1995c)
66 Annonacin Leaf
Peric
Seed
Root
Leaf
Pulp
Nectar
Mono THF, 4OH Cytotoxic
Insecticidal
Antimicrobial
Antitumor
Neurotoxic
Neurodegenerative
Wu et al. (1995c), Guadan˜o et al.
(2000), Liaw et al. (2002),
Jaramillo et al. (2000), Nakanishi
et al. (2003), Champy et al. (2004,
2009), Castillo-Sa´nchez et al.
(2010), and Ko et al. (2011)
67 Annonacin A Peric
Leaf
Seed
Mono THF, 4OH NR Jaramillo et al. (2000) and Wu
et al. (1995c)
68 Annonacin, cis- Seed Mono THF, 4OH Cytotoxic Rieser et al. (1996)
69 Annonacin-10-one, cis- Seed Mono THF, 3OH, 1
carbonyl
Cytotoxic Rieser et al. (1996)
70 Annonacinone
Annonacin 10-one
Leaf
Seed
Pulp
Nectar
Mono THF, 3OH 1
carbonyl
Cytotoxic
Antileishmaniasis
Liaw et al. (2002), Nakanishi
et al. (2003), Champy et al.
(2009), and Vila-Nova et al.
(2013)
71 (2,4-trans)-1OR-annonacin A-
one
Leaf Mono THF, 3OH,
ketolactone
Cytotoxic Wu et al. (1995c)
72, 73, 74 Annopentocin A, B, C Leaf Mono THF, 5OH Cytotoxic Alali et al. (1999)
75 Annoreticuin-9-one Seed Mono THF, 3OH, 1
carbonyl
Cytotoxic Ragasa et al. (2012)
76 Annoreticuin, cis Pulp Mono THF, 4OH Cytotoxic Ragasa et al. (2012)
77 Arianacin Seed Mono THF, 4OH Cytotoxic Alali et al. (1999)
78 Corossolin Seed
Leaf
Mono THF, 3OH Cytotoxic Chang and Wu (2001), Nakanishi
et al. (2003), and Champy et al.
(2009)
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Table 2 (continued)
No Chemical name Part of
plant
Type Bioactivity References
79 Corossolone Leaf
Seed
Pulp
Mono THF, 2OH, 1
carbonyl
Cytotoxic Zafra-Polo et al. (1996), Liaw
et al. (2002), Chang and Wu
(2001), Nakanishi et al. (2003),
and Champy et al. (2009)
80 Cis-corossolone Leaf Mono THF, 2OH, 1
carbonyl
Cytotoxic Liaw et al. (2002) and Nakanishi
et al. (2003)
81 Gigantetrocin A Seed Mono THF, 4OH Cytotoxic
Insecticidal
Alali et al. (1999)
82, Gigantetrocin B Seed Mono THF, 4OH Cytotoxic Alali et al. (1999)
83, 84 2,4 Cis or trans
Gigantetrocinone
Seed Mono THF, 3OH,
ketolactone
NR Li et al. (2001)
85 Gigantetronenin Leaf
seed
Mono THF, 4OH, 1
double bond
Cytotoxic Wu et al. (1995b)
86 Goniothalamicin Seed
Leaf
Mono THF 4OH Cytotoxic Rieser et al. (1996)
87 Cis-goniothalamicin Seed Mono-THF 4OH Cytotoxic Rieser et al. (1996)
88 Isoannonacin Leaf Mono THF, 3OH Rieser et al. (1993),
89, 90 2,4-trans; cis-isoannonacin Leaf
seed
Mono THF NR Wu et al. (1995d) and Li et al.
(2001)
91 2,4-trans-isoannonacin-10-one Seed Mono THF, 3OH,
ketolactone
NR Li et al. (2001)
92 Javoricin Seed Mono THF, 4OH Cytotoxic Rieser et al. (1996)
93 Longifolicin Seed Mono THF, 3OH Cytotoxic Chang and Wu (2001) and
Nakanishi et al. (2003)
94 Montanacin Leaf Mono THF, 5OH Cytotoxic Champy et al. (2009)
95 Montanacin H Leaf
Nectar
MonoTHF, 4OH, 1
carbonyl
Cytotoxic Champy et al. (2009)
96 Muricapentocin Leaf Mono THF, 5OH Cytotoxic Alali et al. (1999)
97 Muricatalicin Leaf Mono THF, 5OH NR Yu et al. (1997)
98 Muricatalin Leaf Mono THF, 5OH NR Yu et al. (1997)
99, 100 Muricatetrocin A,B Seed Mono THF, 4OH Cytotoxic Chang and Wu (2001) and
Nakanishi et al. (2003)
101, 102 Muricatin A, B Seed Mono THF, 5OH NR Zafra-Polo et al. (1996)
103 Muricatin C Bark
Pulp
Nectar
Mono THF, 4OH, 1
carbonyl
NR Zafra-Polo et al. (1996) and
Champy et al. (2009)
104 Muricatin D Seed Mono THF, 5OH NR TDRG (2002);
105 Muricatocin A Leaf
Pulp
Nectar
Mono THF, 5OH Cytotoxic Wu et al. (1995d) and Champy
et al. (2009)
106, 107 Muricatocin B, C Leaf Mono THF, 5OH Cytotoxic Wu et al. (1995d)
108 Muricenin Pulp Mono THF, 4OH Cytotoxic Sun et al. (2014)
109, 110,
111112,
Muricin A,
B, C
D,
Seed Mono THF, 4OH Cytotoxic Chang and Wu (2001), Nakanishi
et al. (2003)
114, 115 Muricin F, G Seed Mono THF, 4OH,
unsaturated
Cytotoxic Chang and Wu (2001)
116 Muricin H Leaf
seed
Mono THF, 3OH Cytotoxic Liaw et al. (2002) and Quispe
et al. (2006)
117 Muricin I Leaf
Seed
Mono THF, 3OH,
unsaturated
Cytotoxic Liaw et al. (2002) and Lannuzel
et al. (2006)
118, 119,
120
Muricin J, K, L Fruit Mono THF, 4OH Cytotoxic Sun et al. (2014)
121 Muricin M Pulp Mono THF, 4OH Cytotoxic Sun et al. (2014)
122 Muricin N Pulp Mono THF, 4OH Cytotoxic Sun et al. (2014)
123 Muricoreacin Leaf Mono THF, 6OH Cytotoxic Alali et al. (1999)
124, 125 Muricoreacin A, B Leaf Mono THF, 5OH Cytotoxic Alali et al. (1999)
126 Murihexocin Leaf Mono THF, 6OH Cytotoxic Alali et al. (1999)
127 Murihexocin A Leaf
Pulp
Mono THF, 6OH Cytotoxic Zeng et al. (1996) and Champy
et al. (2009)
128 Murihexocin B Leaf Mono THF, 6OH Cytotoxic Zeng et al. (1996)
129 Murihexocin C Leaf Mono THF, 6OH Cytotoxic Kim et al. (1998a)
(continued on next page)
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Table 2 (continued)
No Chemical name Part of
plant
Type Bioactivity References
130 Murisolin Seed Mono THF, 3OH Cytotoxic Nakanishi et al. (2003), and Yang
et al. (2010)
131 Cis-panatellin Root Mono THF, 2OH NR Alali et al. (1999)
132 Cis-reticulatacin Root Mono THF, 2OH NR Alali et al. (1999)
133 Cis-reticulatacin-10-one Root Mono THF, 2OH,
carbonyl
NR Alali et al. (1999)
134 Solamin Seed
Stem
Root
Leaf
Mono THF, 2OH Cytotoxic Zafra-Polo et al. (1996), Liaw
et al. (2002), and Nakanishi et al.
(2003)
135 Cis-solamin Root
Leaf
Mono THF, 2OH NR Alali et al. (1999)
136 Cis-solamin A Leaf
Root
Seed
Mono THF, 2OH NR Konno et al. (2008)
137, 138 Cis-uvariamicin I, IV Root Mono THF, 2OH NR Alali et al. (1999)
139 Xylomatenin Pulp Mono THF, 4OH,
unsaturated
Champy et al. (2009)
140 Xylomaticin Seed Mono THF, 4OH Cytotoxic Liaw et al. (2002) and Nakanishi
et al. (2003)
141 Bullatalicin Seed Bis THF nonadjacent,
4OH
Cytotoxic Alali et al. (1999)
142 Gigantecin Seed
Leaf
Bis THF nonadjacent,
4OH
Cytotoxic,
Antitumor in vitro
Champy et al. (2009)
143, 144 Cis-squamostatin A, D Seed Bis THF nonadjacent,
4OH, 3OH
Cytotoxic Yang et al. (2010)
145 Annocatacin A Seed Bis THF adjacent, 2OH Cytotoxic Chang et al. (2003) and
Nakanishi et al. (2003)
146 Annocatacin B Leaf Bis THF adjacent, 2OH Cytotoxic Chang et al. (2003)
147 Asimicinone-9-oxo Leaf Bis THF adjacent, 2OH, 1
carbonyl, keto lactone
Cytotoxic Champy et al. (2009)
148 Asiminecin Seed Bis THF adjacent, 3OH Cytotoxic Yang et al. (2010)
149 Bullatacin Seed Bis TFH adjacent, 3OH Cytotoxic
Antitumor
Neurotoxic
Landolt et al. (1995), Wang et al.
(2002), Nakanishi et al. (2003),
and Yang et al. (2010)
150 Desacetyluvaricin Seed Bis THF adjacent, 2OH NR Yang et al. (2010)
151 Isodesacetyluvaricin Seed Bis THF adjacent, 2OH NR Yang et al. (2010)
152 Robustocin Seed Bis THF adjacent, 1OH NR Gleye et al. (2000a)
153 Rolliniastatin 1, 2 Seed Bis THF adjacent, 3OH Cytotoxic Gromek et al. (1994)
154 Squamocin Seed Bis THF adjacent, 3OH Cytotoxic
Insecticide
Guadan˜o et al. (2000) and
Nakanishi et al. (2003)
155, 156 Montanacin D, E Leaf
Pulp
Mono THF, Mono THP,
2OH, 1 carbonyl
NR Champy et al. (2009)
Phenols
157 Emodin Leaf Anthraquinone NR George et al. (2014)
158 Caﬀeoylquinic acid Leaf Chlorogenic acid NR Marques and Farah (2009)
Pulp Jime´nez et al. (2014)
159 Chlorogenic acid Leaf Chlorogenic acid NR Nawwar et al. (2012)
160 Dicaﬀeoylquinic acid Leaf Chlorogenic acid NR Marques and Farah (2009)
Pulp Jime´nez et al. (2014)
161 Feruloylquinic acid Leaf Chlorogenic acid NR Marques and Farah (2009)
162 Cinnamic acid Leaf
Pulp
Cinnamic acid NR George et al. (2014)
Jime´nez et al. (2014)
163 Apigenin-6-C-glucoside Leaf Flavonoid Antioxidant George et al. (2012)
164 Argentinine Leaf Flavonoid Antioxidant Nawwar et al. (2012)
165 Catechin Leaf Flavonoid Antioxidant Nawwar et al. (2012)
166 Coumarid acid Leaf
Pulp
Flavonoid
Flavonoid
NR George et al. (2014)
Jime´nez et al. (2014)
167 Daidzein Leaf Flavonoid NR George et al. (2014)
168 Dihydrokaempferol-hexoside Pulp Flavonoid NR Jime´nez et al. (2014)
169 Epicatechin Leaf Flavonoid Antioxidant Nawwar et al. (2012)
10 A.V. Coria-Te´llez et al.
Please cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A comprehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
logical activities, mechanisms of action and toxicityAnnona muricata –>. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.004
Table 2 (continued)
No Chemical name Part of
plant
Type Bioactivity References
170 Fisetin Pulp Flavonoid NR Correa-Gordillo et al. (2012)
171 Gallocatechin Leaf Flavonoid NR George et al. (2014)
172 Genistein Leaf Flavonoid NR George et al. (2014)
173 Glycitein Leaf Flavonoid NR George et al. (2014)
174 Homoorientin Leaf Flavonoid Antioxidant George et al. (2014)
175 Isoferulic acid Leaf Flavonoid NR George et al. (2014)
176 Kaempferol Leaf
Pulp
Flavonoid Antioxidant Nawwar et al. (2012)
Sandoval et al. (2014)
177 Kaempferol 3-O-rutinoside Leaf
Pulp
Flavonoid Antioxidant Nawwar et al. (2012)
Sandoval et al. (2014)
178 Luteolin 3´7-di-O-glucoside Leaf
Pulp
Flavonoid Antioxidant George et al. (2012)
Sandoval et al. (2014)
179 Morin Pulp Flavonoid Antioxidant Correa-Gordillo et al. (2012)
180 Myricetin Pulp Flavonoid Antioxidant Correa-Gordillo et al. (2012)
181 Quercetin Leaf Flavonoid Antioxidant George et al. (2012), Nawwar
et al. (2012)
182 Quercetin 3-O-glucoside Leaf Flavonoid Antioxidant Nawwar et al. (2012)
183 Quercetin 3-O-
neohesperidoside
Leaf Flavonoid Antioxidant Nawwar et al. (2012)
184 Quercetin 3-O-robinoside Leaf Flavonoid Antioxidant Nawwar et al. (2012)
185 Quercetin –O-rutinoside Leaf Flavonoid Antioxidant Nawwar et al. (2012)
186 Quercetin 3-O-a-rhamnosyl Leaf Flavonoid Antioxidant Nawwar et al. (2012)
187 Robinetin Leaf Flavonoid Antioxidant George et al. (2012)
188 Tangeretin Leaf Flavonoid NR George et al. (2014)
189 Taxifolin (+) Leaf Flavonoid NR
190 Vitexin Leaf Flavonoid George et al. (2012)
191 Caﬀeic acid Leaf Hydroxycinnamic acid Antioxidant Jime´nez et al. (2014)
192 Gentisic acid Leaf Hydroquinone Antimicrobial
Inhibitor
TDRG (2002)
193 Gallic acid Leaf Tannin George et al. (2012) and Nawwar
et al. (2012);
Other compounds
194, 195,
196
Annoionol A, B, C Leaf Megastigmane NR Matsushige et al. (2011)
197 Annoionoside Leaf Megastigmane NR Matsushige et al. (2011)
198
199
Annomuricatin A, B Seed Cyclopeptides Insecticide Li et al. (1995) and Li et al.
(1998)
200 Annomuricatin C Seed Cyclopeptides Cytotoxic We´le´ et al. (2004)
201 Vitamin A Leaf Vitamin Antioxidant Non published
202 Vitamin C Pulp
leaf
Vitamin, organic acid Antioxidant Vijayameena et al. (2013); non
published
203 Vitamin E (tocopherols) Leaf
Seed
Pulp
Vitamin Antioxidant Vijayameena et al. (2013) and
Correa-Gordillo et al. (2012)
204
205
Carotenes a, b Pulp Carotenoid Antioxidant Correa-Gordillo et al. (2012)
206 Cryptoxanthin b Pulp Carotenoid Antioxidant Correa-Gordillo et al. (2012)
207 Lycopene Pulp Carotenoid Antioxidant Correa-Gordillo et al. (2012);
208 Lutein Pulp Carotenoid Antioxidant Correa-Gordillo et al. (2012)
209 Tocopherol a Pulp Carotenoid Antioxidant Correa-Gordillo et al. (2012)
210
211
Tocotrienol a, c Pulp Carotenoid Antioxidant Correa-Gordillo et al. (2012)
212 N-p-coumaroyl tyramine Leaf Amide Antitumoral Wu et al. (1995c)
NR, Not reported.
Annona muricata 11are reticuline and coreximine (Leboeuf et al., 1981), and leaves
contain the higher alkaloid concentration (Fofana et al., 2011,
2012; Matsushige et al., 2011), although they have also been
found in roots, stems (Leboeuf et al., 1981) and fruit (HasratPlease cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
logical activities, mechanisms of action and toxicityAnnona muricata –>. Arabian Jet al., 1997a, 1997b). The alkaloids reported in A. muricata
are mainly of the isoquinoline, aporphine and protoberberine
type (Mohanty et al., 2008). Their chemical structures and rep-
resentative compounds are shown in Fig. 1. Previous studiesprehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
ournal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.004
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Figure 2 Chemical structures of six types of acetogenins present in A. muricata. (A) Chemical structure of linear derivatives
corresponding to the acetogenins numbers 31–39 of Table 2. (B) Chemical structure of epoxy acetogenins corresponding to the acetogenins
numbers 40–52 of Table 2. (C) Chemical structure of mono THF acetogenins corresponding to the acetogenins numbers 53–140 of
Table 2. (D) Chemical structure of mono THF, mono THP acetogenins corresponding to the acetogenins numbers 155–156 of Table 2. (E)
Chemical structure of Bis-THF nonadjacent acetogenins corresponding to the acetogenins numbers 141–144 of Table 2. (F) Chemical
structure of Bis-THF adjacent acetogenins corresponding to the acetogenins numbers 145–154 of Table 2.
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Figure 1 Chemical structure of alkaloids present in A. muricata. (A) Aporphine type. (B) Protoberberine type. (C). Iminosugar type. (D)
Isoquinoline type. Representative compounds of alkaloids are found in Table 2 at numbers 2, 11, 12 and 27 respectively.
12 A.V. Coria-Te´llez et al.have shown that alkaloids isolated from Annona species pos-
sess an afﬁnity for the 5-HT1A receptors in vitro and partici-
pate in dopamine biosynthesis (Hasrat et al., 1997a, 1997b).
Thus, it has been proposed that alkaloids derived from the
Annona could induce antidepressant-like effects (Hasrat
et al., 1997a, 1997b), and cytotoxic activity (Matsushige
et al., 2012). Neurotoxic effects have also been reported forPlease cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
logical activities, mechanisms of action and toxicityAnnona muricata –>. Arabian Jsome alkaloids, and suggested that neuronal death occurred
by apoptosis (Lannuzel et al., 2002).
3.2. Acetogenins
More than 120 acetogenins have been identiﬁed in ethanolic,
methanolic or another organic extracts of different organsprehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
ournal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.004
CO2H
OH
O
O
OH
OH
A
O
O
OH
OH
OH
OH
B
O OH
OH
C
OH
OH
OH
OH
OH
OH
OH
O OH
D
Figure 3 Chemical structures of types of phenols present in A. muricata. (A) Chlorogenic acid type. (B) Flavonoid type. (C)
Hydroquinone type, (D) Tannin type. Representative compounds of these ﬂavonoids are found in Table 2 for numbers 158, 181, 192 and
193, respectively.
Annona muricata 13and tissues of A. muricata such as leaves, stems, bark, seeds
(Alali et al., 1999; Chang et al., 2003; Li et al., 2001; Liaw
et al., 2002), pulp (Ragasa et al., 2012), and fruit peel
(Jaramillo et al., 2000) (Table 2). Acetogenins are character-
ized by a long aliphatic chain of 35 to 38 carbons bonded to
a c-lactone a ring, terminally substituted by b-unsaturated
methyl (sometimes it is a ketolactone), with one or two
tetrahydrofurans (THF) located along the hydrocarbon chain
and a determined number of oxygen groups (hydroxyl, ace-
toxyls, ketones, epoxy). Most of the acetogenins found in A.
muricata contain a THF ring, although acetogenins have also
been reported with two adjacent or nonadjacent THF rings.
Acetogenins are linear and may have one or two epoxy groups.
Fig. 2 shows the six basic chemical structures of acetogenins
reported for A. muricata. Some studies suggested that its
bioactivity depends on its structure (Landolt et al., 1995).
Annonacin was the most abundant acetogenin reported in
both, leaves (Liaw et al., 2002) and fruit (Champy et al.,
2005, 2009) of A. muricata, but has also been reported in seeds
(Wu et al., 1995a), peel (Jaramillo et al., 2000) and roots
(Champy et al., 2004). The contents of acetogenins in leave
extracts range from 3.38 to 15.05 mg/g measured by A 1H
NMR, while HPLC-MALDI quantiﬁed 0.299 mg/g
(Machado et al., 2014). Acetogenins are considered the main
bioactive compounds of the Annonaceae family (Alali et al.,
1999). Some studies have shown that acetogenins are more
cytotoxic than alkaloids and rotenone, a synthetic cytotoxic
compound. Acetogenins and alkaloids are widely studied in
a controversial form, due to their therapeutic potential versus
neurotoxic activity.
3.3. Phenolic compounds
Thirty-seven phenolic compounds have been reported to be
present in A. muricata (Table 2). The important phenolic com-
pounds found in A. muricata leaves include quercetin (NawwarPlease cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
logical activities, mechanisms of action and toxicityAnnona muricata –>. Arabian Jet al., 2012) and gallic acid (Correa-Gordillo et al., 2012). The
presence of ﬂavonoids and lipophilic antioxidant compounds
such as tocopherols and tocotrienols has been reported to be
present in the pulp (Correa-Gordillo et al., 2012). In different
studies, when organic or aqueous extracts have been used, the
quantity of extractable total phenols is considerably different.
This is important to mention because the most common medic-
inal use is aqueous infusion and the majority of phenols are
soluble in water. Phenolic compounds are considered as the
major phytochemicals responsible for the antioxidant activity
(George et al., 2014).
3.4. Other compounds
Other compounds such as vitamins, carotenoids, amides,
cyclopeptides and megastigmanes have also been identiﬁed in
A. muricata (Table 2). Vitamins and carotenoids have been
found in leaves, seeds and fruit pulp (Correa-Gordillo et al.,
2012; Vijayameena et al., 2013). The presence of the amide
N-p-coumaroyl tyramine (Wu et al., 1995c) and cyclopeptides
(Li et al., 1998; We´le´ et al., 2004) has been reported in the seeds
and showed to have anti-inﬂammatory and anti-tumor effects.
Megastigmanes are present in leaves of A. muricata but had no
cytotoxic or antioxidant activity (Matsushige et al., 2011).
Examples of chemical structures of these compounds are
shown in Fig. 3.
On the other hand, 37 volatile compounds have been
identiﬁed in the fruit pulp of A. muricata, and most of
these compounds are aromatic and aliphatic esters
(Cheong et al., 2011). In addition, 80 essential oils, mainly
sesquiterpenes derivates (Kossouoh et al., 2007; Thang
et al., 2012), have been identiﬁed in the leaf and have
shown cytotoxic activity against MCF-7 (human breast car-
cinoma) cell line (99.2% kill at 100 lg/ml) (Owolabi et al.,
2013). The study of volatiles of A. muricata is promising
because of their bioactivity.prehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
ournal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.004
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Figure 4 Chemical structure of some compounds present in A. muricata. (A) Megastigmane type. (B) Vitamin type. (C) Cyclopeptide
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respectively.
14 A.V. Coria-Te´llez et al.4. Pharmacological activities
From the 50 reports of pharmacological studies we have reviewed
for this manuscript, about 66% corresponded to in vitro studies,
32% to in vivo studies in murine models, and 2% to clinical stud-
ies. Regarding the type of extracts used, 84% corresponded to
maceration of any part of the plant in organic solvents and
16% corresponded to aqueous preparations.
4.1. In vitro studies
Most of the in vitro studies correspond to cytotoxic activity
(30%) followed by antiprotozoal activity (23%) and insectici-
dal activity (18%). The remaining 29% was conformed to
antioxidant activity and antimicrobial and antiviral activities,
among others (Table 3).
4.1.1. Cytotoxic activity
The increasingly popular use of A. muricata as an anticancer
treatment reported ethnobotanically may be related to reports
of its selective cytotoxic activity (George et al., 2012). ThisPlease cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
logical activities, mechanisms of action and toxicityAnnona muricata –>. Arabian Jbioactivity is considered selective as some of the extracts stud-
ied in vitro were shown to be more toxic to cancer cell lines
than to normal cells (Betancur-Galvis et al., 1999; Dai et al.,
2011; George et al., 2012; Valencia et al., 2011;
Gavamukulya et al., 2014). Nawwar et al. (2012) reported that
1.6 lg/ml and 50 lg/ml from hydroalcoholic extract of A.
muricata leaves increased the viability of non-cancerous cells
while 100 lg/ml did not alter their viability. This selective
activity has also been reported to induce healing. In tumor
cells, healing time is increased (Torres et al., 2012), whereas
in rodents, healing time of induced wound decreases
(Padmaa et al., 2009). Likewise, in the study of other bioactiv-
ities, the type of extract is decisive in the results obtained.
Organic solvents, pentanoic and ethanolic, were the most
active A. muricata extracts against cancer cells grown
in vitro. In these extracts, activity has been reported to be 10
and 4.5 times higher, respectively, than the activity of the aque-
ous extract in the A375 cell culture (Me´nan et al., 2006).
According to Osorio et al. (2007), extracts with LC50 < 10
lg/ml can be classiﬁed as highly cytotoxic while the National
Cancer Institute (Pieme et al., 2014) suggested that plant
extracts with LC50 values 620 lg/ml are suitable for cancerprehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
ournal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.01.004
Table 3 Pharmacological activities of A. muricata extract evaluated in vitro.
Activity Plant part Solvent Test model Eﬀect References
Cytotoxic Leaf H2O:EtOH 40% K562
ECV-304
MIC = 7 mg/ml
MIC = 2 mg/ml
Oviedo et al. (2009)
Peri MeOH
Hex
EtOAc
U-937 MEC> 1 mg/ml
MEC= 1 mg/ml
MEC= 0.1 mg/ml
Jaramillo et al. (2000)
Dried fruit H2O:Cet 50% MCF-10A
BC MDA-MB-468
MDA-MB-231
MCF-7
IC50 > 200 lg/ml
IC50 = 4.8 lg/ml
IC50 > 200 lg/m
IC50 > 200 lg/m
Dai et al. (2011)
Leaf EtOAc U-937 LC50 = 7.8 lg/ml Osorio et al. (2007)
Stem EtOAc
MeOH
Hex
EtOAc
MeOH
Hex
IC50 = 10.5 lg/ml
IC50 = 60.9 lg/ml
IC50 = 18.2 lg/ml
IC50 = 28.1 lg/ml
IC50 = 38.5 lg/ml
IC50 = 15.7 lg/ml
Valencia et al. (2011)
Leaf EtOH VERO
H460
C-678
IC50 < 0.00022 mg/ml
IC50 < 0.00022 mg/ml
IC50 < 0.00022 mg/ml
Quispe et al. (2006)
Leaf/
stem
DMSO PC FG/COLO357
PC CD18/HPAF
IC50 = 200 lg/ml
IC50 = 73 lg/ml
Torres et al. (2012)
Leaf n-But MDA-MB-435S
HaCaT
WRL-68
IC50 = 29.2 lg/ml
IC50 = 30.1 lg/ml
IC50 = 52.4 lg
George et al. (2012)
H2O:EtOH HaCat 1.6 to 50 lg/ml increase cellular
activity,
100 lg/ml not change cell behavior
Nawwar et al. (2012)
H2O
EtOH
Pen
A375 IC50 > 500 lg/ml
IC50 = 320 lg/ml
IC50 = 140 lg/ml
Me´nan et al. (2006)
EtOH MCF-7
H-460
SF-268
ED50 = 6.2 lg/ml
ED50 = 4.0 lg/ml
ED50 = 8.5 lg/ml
Caldero´n et al. (2006)
Leaf
Seed
EtOH MDBK CC50 = 20x10–4 lg/ml
CC50 = 24x10–5 lg/ml
Betancur-Galvis et al.
(1999)
Leaf EtOAc
EtOH+H2O
Chl
n-Hex
HeLa 15.62 lg/ml = 11.37% inh
15.62 lg/ml = 3.97% inh
15.62 lg/m l = 18.42% inh
15.62 lg/ml = 21.41% inh
Astirin et al. (2013)
n-Hex
EtOAc
MeOH
n-Hex
EtOAc
MeOH
n-Hex
EtOAc
MeOH
HT-29
HCT-116
CCD841
IC50 = 14.93 lg/ml
IC50 = 4.29 lg/ml
IC50 > 100 lg/ml
IC50 = 12.26 lg/ml
IC50 = 3.91 lg/ml
IC50 > 100 lg/ml
IC50 = 42.19 lg/ml
IC50 = 34.24 lg/ml
IC50 > 100 lg/ml
Moghadamtousi et al.
(2014)
EtOH Spleen cell
EACC
MDA
SKBR3
T47D
IC50 > 750 lg/ml
IC50 = 335.85 lg/ml
IC50 = 248.77 lg/ml
IC50 = 202.33 lg/ml
IC50 = 17.15 lg/ml
Gavamukulya et al.
(2014)
Rachmani et al. (2012)
Leaf
Twigs
Roots
EtOH HL-60 IC50 = 14 lg/ml
IC50 = 49 lg/ml
IC50 = 9 lg/ml
Pieme et al. (2014)
Leaf
Com leaf
Hex
DMSO
Capan-1 IC25 = 7.8 lg/ml
IC25 = 0.9 lg/ml
Mohamad et al. (2015)
Antiprotozoal Leaf H2O
EtOH
Pen
Plasmodium falciparum
(chloroquine-sensitive
strain)
IC50 = 240 lg/ml
IC50 = 52 lg/ml
IC50 = 18 lg/ml
Me´nan et al. (2006) and
Nguyen-Pouplin et al.
(2007)
H2O
EtOH
Plasmodium falciparum
FcM29
IC50 = 230 lg/ml
IC50 = 49 lg/ml
(continued on next page)
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Table 3 (continued)
Activity Plant part Solvent Test model Eﬀect References
Pen IC50 = 16 lg/ml
EtOH
MeOH
Ip
Hex
H2O
Plasmodium falciparum
strain W2
IC50 = 7.43 lg/ml
IC50 = 3.55 lg/ml
IC50 > 10 lg/ml
IC50 = 2.03 lg/ml
IC50 > 10 lg/ml
Boyom et al. (2011)
Twig EtOH
MeOH
Hex
H2O
IC50 = 8.56 lg/ml
IC50 = 4.11 lg/ml
IC50 > 10 lg/ml
IC50 > 10 lg/ml
Flow EtOH
MeOH
H2O
IC50 = 5.12 lg/ml
IC50 = 2.92 lg/ml
IC50 > 10 lg/ml
Peric EtOH
MeOH
Ip
H2O
IC50 = 6.87 lg/ml
IC50 = 4.3 lg/ml
IC50 > 10 lg/ml
IC50 > 10 lg/ml
Pulp EtOH
MeOH
Pp
H2O
IC50 = 6.01 lg/ml
IC50 = 5.17 lg/ml
IC50 = 4.42 lg/ml
IC50 > 10 lg/ml
Seed EtOH
MeOH
Pp
H2O
IC50 = 3.02 lg/ml
IC50 = 2.42 lg/ml
IC50 > 10 lg/ml
IC50 > 10 lg/ml
Leaf
Stem
Hex
EtOAc
MeOH
Hex
EtOAc
MeOH
Plasmodium falciparum
F32/W2
IC50 = 7 lg/ml /38 lg/ml
IC50 = 8 lg/ml /10 lg/ml
IC50 = 9 lg/ml/36 lg/ml
IC50 = 11 lg/ml/38 lg/ml
IC50 = 40 lg/ml/34 lg/ml
IC50 = 32 lg/ml/26 lg/ml
Osorio et al. (2005)
Leaf MeOH Plasmodium falciparum
3D7
IC50 = 0.715 lg/ml Yamthe et al. (2015)
Peri
Root
Steam
EtOH Plasmodium falciparum
strain W2
IC50 = 1.01 lg/ml
IC50 = 0.79 lg/ml
IC50 = 1.45 lg/ml
Boyom et al. (2011)
Peri MeOH
Hex
EtOAc
Leishmania braziliensis MEC> 1 mg/ml
MEC> 1 mg/ml
MEC= 0.1 mg/ml
Jaramillo et al. (2000)
Leaf
Stem
Hex
EtOAc
MeOH
Hex
EtOAc
MeOH
Leishmania sp. IC50 > 100 lg/ml
IC50 = 25 lg/ml
IC50 > 100 lg/ml
IC50 = 76.3 lg/ml
IC50 = 63.2 lg/ml
IC50 = 98.6 lg/ml
Osorio et al. (2007)
Leaf EtOH Biomphalaria glabrata 500 ppm, 100% mort Luna et al. (2005)
Leaf
Stem
Bark
EtOAc
MeOH
Hex
Hex
EtOAc
MeOH
EtOH
Trypanosoma cruzi
Entamoeba histolytica
IC50 = 40.2 lg/ml
IC50 > 200 lg/ml
IC50 > 200 lg/ml
IC50 = 91 lg/ml
IC50 = 93.5 lg/ml
IC50 > 200 lg/ml
MIC = 63 mcg/ml
Valencia et al. (2011)
Ross (2010)
Leaf H2O Haemonchus contortus 12.5% extract 90% of larvae mot Ferreira et al. (2013)
Insecticidal Seed EtOH Spodoptera litura larvae 5% extract, 18–96% inh Leatemia and Isman
(2004)
PE A. aegypti
An. albimanus
A. aegypti
An. albimanus
18.75 ppm, 15% mort
4.7 ppm, 85% mort
37.5 ppm, 3% mort
9.4 ppm/, 2.5% mort
Morales et al. (2004)
Leaf and
Bark
H2O A. aegypti 5% extract, 99% mort Sanabria et al. (2009)
Flow EtOH/ A. aegypti CL50 = 3.33 mg/ml Bobadilla et al. (2005)
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Table 3 (continued)
Activity Plant part Solvent Test model Eﬀect References
Seed
Leaf
Stem
Root
H2O CL50 = 0.02 mg/ml
CL50 = 8.25 mg/ml
CL50 = 19.21 mg/ml
CL50 > 50 mg/ml
Leaf EtOH Plutella xylostella 5 mg/ml by 12 days: 100% larvae
mort
Pre´des et al. (2011)
EtOH Callosobruchus
maculatus Fabricius
1 g/l, 40.8% mort Adeoye and Ewete
(2010)
Seed EtOH/n-Hex A. aegypti LC50 = 73.77 ppm Komansilan et al. (2012)
EtOH
DicMet
H2O
Cx. Quinquefascia-tus 1 ml extract, 22% mort
1 ml extract, 22% mort
20% extract, 11.5% mort
Raveloson et al. (2014)
DicMe Ae. albopictus 1 ml extract, 25% mort
Repellent Seed EtOH C. gestroi Wasmann 20% extract, 15.75% mort Acda (2014)
Antioxidant Juice NR ABTS
DPPH
6.09 lM of Tr/g
1.36 lM of Tr/g
Almeida et al. (2011)
Pulp NR FRAP
ORAC
ABTS
DPPH
Lipid peroxidation
503 lmol/l/g
14.51 lmol of Tr/g
287.67 lmol of Tr/g
2.88 lmol of Tr/g
3.5% with 10 lM GAE
Correa-Gordillo et al.
(2012)
Leaf MeOH
EtOH
DPPH
DPPH
ABTS
Lipid peroxidation
Follow nitric oxide
radical
Follow superoxide
radical
IC50 = 221 lg/ml
IC50 = 70 lg/ml
IC50 = 305 lg/ml
IC50 = 455 lg/ml
IC50 = 350 lg/ml
IC50 = 155 lg/ml
Leaf H2O:EtOH (3:1) ORAC assay 14269537.4 lM Tr/g Nawwar et al. (2012)
Fresh leaf H2O DPPH SC50 = 10.1 mg/l Alitonou et al. (2013)
Leaf n-But DPPH 400 lg of extract, 60% inh George et al. (2012)
Fresh-leaf
Dried-leaf
Pulp
Seed
EtOH
MeOH
EtOH
MeOH
EtOH
MeOH
EtOH
MeOH
ABTS 219.2 lmol of Tr/100 g
182.3 lmol of Tr/100 g
280.2 lmol of Tr/100 g
160.8 lmol of Tr/100 g
306 lmol of Tr/100 g
193.4.2 lmol of Tr/100 g
131.2 lmol of Tr/100 g
86.6 lmol of Tr/100 g
Vit and Santiago (2014)
Pulp MeOH DPPH 5 mg of pulp, 75.39% inh Boakye et al. (2015)
Antibacterial Peel H2O S. aureus
V. cholera
E. coli (river)
50 lL/dish, DIH= 14 mm
50lL/dish, DIH= 17 mm
50lL/dish, DIH= 18 mm
Viera et al. (2010a)
Leaf EtOH
H2O:EtOH
S. aureus
E. coli EC27
MIC = 128 mg/ml
MIC > 1024 lg/ml
Bussmann et al. (2010)
Bento et al. (2013)
H2O/ MeOH B. subtilis
S. aureus
K. pneumonia
S. typhimurium
E. coli
S. pyogenes
400 mg/ml, DIH= 18.5/19.5m
400 mg/ml, DIH= 17.7/20.5m
400 mg/ml, DIH= 16.0/18.0m
400 mg/ml, DIH= 16.5/16.5m
400 mg/ml, DIH= 17.5/16.5m
400 mg/ml, DIH= 0/17.2 m
Solomon-Wisdom et al.
(2014)
Seed, Stem MeOH E. coli C600
S. aureus 209P
MIC > 1024 lg/ml
MIC > 1024 lg/ml
Yasunaka et al. (2005)
Leaf H2O M. tuberculosis H37Rv
M. tuberculosis MDR
5 mg/ml of extract, 82% inh
5 mg/ml of extract, 50% inh
Radji et al. (2015)
EtOH S. thypimurium
S. thypimurium A
S. thypimurium B
MIC= 4096 lg/ml
MIC = 2048 lg/ml
MIC = 4046 lg/ml
Roger et al. (2015)
(continued on next page)
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Table 3 (continued)
Activity Plant part Solvent Test model Eﬀect References
Antiviral Stem EtOH Herpes simplex HSV-1
strain #753166
MIC = 1 mg/ml Padma et al. (1998)
Leaf EtOH
EtOH
Spleen cell
EACC
MDA
SKBR3
T47D
IC50 > 750 lg/ml
IC50 = 335.85 lg/ml
IC50 = 248.77 lg/ml
IC50 = 202.33 lg/ml
IC50 = 17.15 lg/ml
Gavamukulya et al.
(2014)
Rachmani et al. (2012)
Leaf
Twigs
Roots
EtOH HL-60 IC50 = 14 lg/ml
IC50 = 49 lg/ml
IC50 = 9 lg/ml
Pieme et al. (2014)
Leaf Hex
DMSO
Capan-1 IC25 = 7.8 lg/ml
IC25 = 0.9 lg/ml
Mohamad et al. (2015)
Leaf H2O BPH-I IC50 = 1.36 mg/ml Asare et al. (2014)
NR, no reported; Cell line: ECV304, Human leukemia carcinoma cells; FG/COLO357 and CD18/HPAF, Pancreatic cancer cells; U937,
Histiocytic lymphoma cell line; HeLa, Uterine cervical cancer cell line; MDA-MB-435S, Breast carcinoma cells; HaCat, immortalized human
keratinocytes; WRL-68, normal human liver cells; MBDK, Bovine cell line; MCF-7, human breast carcinoma; K562, Human bladder carci-
noma cells; H-460, Human large lung cell carcinoma; S-F-268, glioma; CCD841, normal human colon epithelial cells; HT-29 and HCT-116,
colon cancer cell. VERO, kidney epithelial cells; C-678, stomach cancer cells; EACC: Ehrlich Ascites Carcinoma Cells; SKBR3: breast
adenocarcinoma cell line; T47D, breast cancer cells; HL-60, human promyelocytic leukemia; Capan-1, pancreatic cancer cells; BPH-I, human
benign prostate cells. Concentration: MEC: minimum effective concentration; MIC, minimum inhibitory concentration; IC50, medium inhi-
bitory concentration; DIH, Diameter of inhibitory halo (mm); SC50, medium scavenging activity; ED50, medium effective dose; CC50, 50%
cytotoxic concentration; CL50, 50% lethal concentration; inh, inhibitory; Ip, Interface precipitate. Extract: n-but, butanol; Chl, chloroform;
EtOAc, ethyl acetate; EtOH, ethanol; Hex, hexane; n-hex, n-hexane; H2O, water; MeOH, methanol; PE, petroleum ether; Pen, pentane.
Chemical: Tr, trolox; GAE, gallic acid equivalent. Activity: FRAP, Power reduction of iron; ORAC, Oxygen radical absorbance capacity;
ABTS, Radical cation capture 2,2-azino-bis(3-ethylbenzthiazoline)-6 ammonium sulfonate; DPPH, 1,1-diphenyl-2-picrylhydrazyl radical
activity. Plant part: ﬂow, ﬂower; peric, pericarp. Inh, inhibition; mor, mortality; MDR, multi drug resistant.
18 A.V. Coria-Te´llez et al.drugs from plants. Ethyl acetate A. muricata leaf extract
showed inhibition of the U-937 cell line with 7.8 lg/ml
(Osorio et al., 2007). Although A. muricata extracts exhibit
good cytotoxicity, there are plants with more cytotoxic effect,
like Thevetia ahouai with LC50 < 1 lg/ml. Both plant species
are used in Latin American countries to treat cancer
(Caldero´n et al., 2006). The hexane extract of leaves had the
highest content of ﬂavonoids and the most effective inhibition
of cell proliferation than the methanol or chloroform extracts
(Mohamad et al., 2015). Moghadamtousi et al. (2015c) and
Pieme et al. (2014) proposed that the mechanism of action of
the extract implies the disruption of mitochondrial membrane
to arrest cells in G0/G1 phase, and the induction of apoptosis
suppressing the migration and invasion of cancer cells. Pieme
et al. (2014) suggested that A. muricata extracts induce apopto-
sis by Reactive Oxygen Species (ROS), and downregulates Bcl-
2 proteins. Bax protein Bcl-2 are anti-apoptotic proteins that
suppress the function of apoptosis, while Bax are proteins that
mediate the leakage of pro-apoptotic factors, including cyto-
chrome c, Ca2+ and the mitochondrial protein Smac/DIABLO
into the cytosol through dimerization and translocation to the
outer mitochondrial membrane; a property that was also
observed for acetogenins (Asare et al., 2014).
The acetogenins with antitumor and anticancer activity
have also been studied in vitro assays, and cytotoxic effects
against more than 15 cancer cell lines have been used
(Alonso-Castro et al., 2011; Chang and Wu, 2001; Kim
et al., 1998a, 1998b; Ko et al., 2011; Liaw et al., 2002;
Quispe et al., 2006; Torres et al., 2012; Zeng et al., 1996). Iso-
lated acetogenins have demonstrated selective cytotoxic effects
(Moghadamtousi et al., 2015c). Acetogenins bioactivity hasPlease cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
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1995; Nakanishi et al., 2003). The two adjacent THF rings ace-
togenins are the most active (Table 2) (Castillo-Sa´nchez et al.,
2010; Nakanishi et al., 2003; Yang et al., 2010), especially bul-
latacin and squamocin (Table 2), which have been reported
mainly in the seeds (Landolt et al., 1995; Nakanishi et al.,
2003). The mechanism of the acetogenin cytotoxic action is
the inhibition of the mitochondrial complex I (Lannuzel
et al., 2003), and the inhibition of ubiquinone-linked NADH
oxidase in the plasma membranes of cancerous cells causing
apoptosis (Alali et al., 1999). Torres et al. (2012) demonstrated
that A. muricata extracts suppressed phosphorylation of the
key molecules involved in the extracellular signal-regulated
kinase (ERK) and the phosphatidylinositol 3’kinase (PI3 K/
Akt) pathway which play a crucial role in the proliferation
and survival of pancreatic cancer cells. Also, plant extract
inhibited the expression of glucose transporter and glycolytic
enzymes, all of which lead to the reduction of glucose uptake
and ATP production by PC cells (Torres et al., 2012).
Biochemical apoptosis implied a transverse redistribution
of phosphatidylserine (PS) on the outer plasma membrane
arises during early apoptosis (Moghadamtousi et al., 2015c).
Other events in apoptosis are the complex cascade of caspases.
Annomuricin E caused depletion of mitochondrial membrane
potential (MMP) leading to opening of mitochondrial perme-
ability transition pores and further release of pro-apoptotic
proteins, such as cytochrome c from the mitochondria to the
cytosol, resulting in the formation of the apoptosome and
the activation of caspase 9 and caspase 3/7, which have been
linked to the mitochondrial death pathway. A. muricata
extracts isolated Annomuricin E downregulates Bcl-2 proteinsprehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
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nacin E-induced apoptosis was through the mitochondrial-
mediated pathway (Moghadamtousi et al., 2015c).
McLaughling (2008) suggested that selective cytotoxicity of
A. muricata is due to the enhanced ATP demand of cancer cells
with respect to normal cells.
4.1.2. Anti-protozoal activity
A. muricata extracts and some of their isolated compounds
have shown effectiveness against protozoans responsible for
human diseases (Table 3), as is the case of the genera Plas-
modium (Boyom et al., 2011), Leishmania (Osorio et al.,
2007), Biomphalaria (Luna et al., 2005), Trypanosoma, and
Entamoeba (Ross, 2010), responsible for malaria, leishmania-
sis, schistosomiasis, chagas, and amebiasis diseases, respec-
tively. The anti-plasmodic effect has particular interest due
to the necessity for antimalarial drugs in tropical areas.
Methanol extract of this species has shown inhibition of this
parasite in vitro but with less effectivity than the commercial
drugs chloroquine and artemisinin (Boyom et al., 2011). The
highest effectiveness was found in seed extracts (Boyom et al.,
2011). It has also been reported that alkaloids (Fofana et al.,
2011, 2012), acetogenin, anonaine, and gallic acid (Yamthe
et al., 2015) isolated from A. muricata had antiplasmodial
activity. It has been demonstrated that phenolic compounds
inhibit the activity of b-ketoacyl-ACP-reductase (FabG), b-
hydroxyacyl-ACP-dehydratase (FabZ) and enoyl acyl-ACP
reductase (FaBI), important enzymes for fatty acid biosynthe-
sis in P. falciparum that compromises its growth (Tasdemir
et al., 2006). In the case of FabG, phenols like luteolin act
as noncompetitive inhibitor of FabG with respect to
acetoacetyl-CoA as well as NADPH, while in FabZ, luteolin
acts as competitive inhibitor of the substrate crotonyl-CoA
(Tasdemir et al., 2006).
Methanolic and ethyl acetate extracts of A. muricata peel
showed higher antileishmanial activity than the commercial
compound Glucantime (Jaramillo et al., 2000) used to treat
diseases caused by different strains of protozoa.
The trypanocidal activity of A. muricata was found in
extracts from different plant parts and in different solvents,
although its effectiveness was 100 times lower than the com-
mercial trypanocide benznidazole (Osorio et al., 2007;
Valencia et al., 2011). Extracts of A. muricata also have
antiparasitic activity against the metazoan or helminth Hae-
monchus contortus, a gastrointestinal parasite of sheep
(Ferreira et al., 2013). The extracts of A. muricata were active
against eggs, infective larvae and adult forms of the parasite,
and the effect was comparable to that obtained with using
the anthelmintic drug, levamisole (Ferreira et al., 2013).
Isoquinoline alkaloids are strongly implicated in the inhibi-
tion of an essential antioxidant enzyme of Leishmania and Try-
panosoma, trypanothione reductase. This enzyme protects the
parasites from ROS generated by the host defense cells
(Tempone et al., 2005).
4.1.3. Insecticidal, larvicidal and repellent activity
A. muricata showed insecticidal activity from seed, leaves,
barks, stems, roots and ﬂowers (Bobadilla et al., 2005;
Leatemia and Isman, 2004; Pre´des et al., 2011). Ethanolic
extracts inhibited insect larvae of Aedes aegypti (Bobadilla
et al., 2005; Morales et al., 2004; Sanabria et al., 2009),Please cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
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affect plants such as Spodoptera litura (Leatemia and Isman,
2004), Callosobruchus maculatus and Plutella xylostella
(Pre´des et al., 2011). A. muricata seed extracts have shown
the most active insecticidal activity (Bobadilla et al., 2005;
Morales et al., 2004; Sanabria et al., 2009), probably due to
its content of chemical compounds such as alkaloids, fatty
acids and acetogenins. The insecticidal action of soursop alka-
loids has not been fully studied. Fatty acids are toxic to insects
in different manners: by inhalation of volatile compounds, by
contact with ﬁlm at the surface of water, and by penetration
due to the amphibolic property of some compounds
(Raveloson et al., 2014). New technologies, such as nano
science, are exploring the development of environmentally
friendly, effective, inexpensive and easy to apply mosquito
control products. For this purpose, green silver nanoparticles
synthesized using aqueous crude extract of A. muricata show
larvae toxicity of Aedes aegypti (Santhosh et al., 2015).
Acetogenins have in vitro activity on larvae of Myzus persi-
cae, Leptinotarsa decemlineata, Blattella germanica, Aedes
aegypti, Rhodnius prolixus, and Rhodnius pallescens (Castillo-
Sa´nchez et al., 2010; Guadan˜o et al., 2000). In studies that
have evaluated the insecticidal activity of 44 acetogenins iso-
lated from different species of Annona, there was a relationship
between the acetogenin structure and their toxicity to mos-
quito larvae. As such, compounds with adjacent bis-
tetrahydrofuran rings and three hydroxyls were more active
than compounds with a mono-tetrahydrofuran ring. The
majority of the active acetogenins evaluated in a study by
Isman and Akhtar (2007) were equitoxic to the commercial
compound rotenone (LC50 = 1.2 ppm). Some studies have
suggested that the insecticidal mechanisms of acetogenins are
due to THF ring having strong interaction with the interface
of lipid bilayers, and alkyl spacer between the c-lactone and
hydroxylated THF ring moieties elicited potent inhibitory
activities on the NADH oxidase, resulting in the inhibition
of mitochondrial complex I (Guadan˜o et al., 2000; Isman
and Akhtar, 2007), and thus damaging the respiration chain
and the integrity and function of the cell. Using the insecticidal
activity of isolated acetogenins as a base, commercial products
were developed but failed mainly because their mechanism of
action involves inhibition of mitochondrial electron transport
with a speciﬁc action at complex I, thus becoming detrimental
to other organisms. In the case of other plants, using crude
extracts can be more promising than the development of prod-
ucts using individually isolated compounds as active ingredient
(Isman and Akhtar, 2007).
4.1.4. Antioxidant activity
Natural antioxidants from plant species have gained interest
due to their protective effect against oxygen-derived from
free radicals involved in the development of many diseases
such as cancer, cardiovascular affections, arthritis, as well
as degenerative illness such as Parkinson and Alzheimer
(Almeida et al., 2011). Several antioxidant screenings have
been conducted on A. muricata (Table 3). Correa-Gordillo
et al. (2012) compiled studies on the antioxidant activity
of A. muricata considering different assays, the different
plant parts, and the different solvents used. Some of the
methods used for determining the total antioxidant capacity
included the free radical scavenging capacities using DPPHprehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
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the ORAC assay, reduction power by the FRAP assay and
b-carotene bleaching.
The antioxidant activity has been evaluated in fresh and
frozen pulp, juice, and fresh or dried leaves. The pulp antiox-
idant activity measured by ABTS, FRAP and ORAC sug-
gested that the antioxidant compounds from A. muricata are
mainly lipophilic, and the mechanism of action is by hydrogen
donation (Correa-Gordillo et al., 2012).
The composition of the extract varies depending on
the solvent used. For example, methanolic, ethanolic,
n-butanolic and aqueous leaf extracts showed different
antioxidant activity measured by DPPH. For instance, the
aqueous extract of fresh leaves of A. muricata was 1000 times
less active than the commercial antioxidant butylated hydrox-
ytoluene (Alitonou et al., 2013). A positive correlation
between antioxidant activity and the total polyphenol content
was reported (George et al., 2012). Antioxidant activities of
phenols, ﬂavonoids, vitamins and carotenoids in A. muricata
are summarized in Table 2.
4.1.5. Antibacterial and antiviral activities
A. muricata showed antibacterial activity against gram-
positive and gram-negative bacteria, comparable with the
standard antibiotic streptomycin (Table 3). Its bioactivity
efﬁcacy depends on the kind of solvent used in the extrac-
tion. For example, ethanolic and methanolic extracts of
A. muricata showed antibacterial activity against Staphyloco-
cus aureus, while the peel aqueous extract did not show such
activity. In addition to the direct antimicrobial activity, a
modulatory activity has also been reported. The combination
of ethanolic extract and antibiotic treatment increased the
potentiation of the antibiotic against multidrug-resistant
strains of E. coli and S. aureus (Viera et al., 2010; Bento
et al., 2013; Solomon-Wisdom et al., 2014). Ethanolic extracts
from stem and bark of A. muricata also showed antiviral
activity in vitro against the Herpes simplex virus (Padma
et al., 1998).
Antimicrobial bioactivity of A. muricata extracts is attribu-
ted to ﬂavonoids, steroids and alkaloids present in the plant
extracts (Radji et al., 2015). The mechanism of action is prob-
ably due to a synergism of these compounds. It has been
reported that some alkaloids have the ability to bind with
DNA of microorganisms and inhibit RNA synthesis (Roger
et al., 2015), and have shown antimicrobial activity by glycosi-
dase inhibition (Mohanty et al., 2008). It has also been
reported that ﬂavonoids act by inhibiting both cytoplasmic
membrane function and DNA synthesis, such as quercetin that
binds to GyrB subunit of E. coli DNA gyrase and inhibits the
enzyme ATPase activity. Phenylphenol was reported to bind to
membrane protein or hydrogen with vital proteins such as
microbial enzymes and inhibit and change their functions
(Radji et al., 2015).
With respect to antiviral bioactivity, it is known that plant
extracts interfere with HIV-I replication at an early step of the
virus. In the ﬁrst step, plant extracts interfere with virus entry
into the host cell by reduction of input viral RNA and by inter-
fering with the function of the envelope proteins that diminish
the infectivity of viral particles. This indicates that plant
extracts have virucidal activity and act before the interaction
with the host cell. Also, plant extracts inhibit attachment ofPlease cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
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of plant extracts is mediated by polyphenol compounds (Helfer
et al., 2014).
4.2. In vivo studies of extracts and isolated compounds
The most encountered in vivo studies were hypoglycemic, anti-
tumorigenic, hepato and gastro protective studies. The phar-
macological activities of A. muricata extracts evaluated
in vivo are summarized in Table 4.
4.2.1. Hypoglycemic activity
A. muricata leaf extracts showed hypoglycemic activity in mur-
ine models (Adewole and Caxton-Martins, 2006). In these
studies, the effect of aqueous and methanolic extracts of A.
muricata leaves on reducing the concentration of blood glucose
in rats with diabetes induced with streptozotocin (STZ) was
evaluated, and the histology and biochemistry of the pancreas
were observed. Pancreatic b-cells in rats that were adminis-
tered with extracts of A. muricata did not show the alterations
that are normally found in diabetic rats. An increase in the
antioxidant enzymatic activity and insulin content in pancre-
atic serum was reported. Near normal blood glucose levels,
body weight, food and water intake, lipid proﬁle and oxidative
defense were achieved after a month of daily treatment with A.
muricata extract, which could prevent the deleterious effect of
STZ by its antioxidant and protective effect of pancreatic b-
cells (Florence et al., 2014). It has also been reported that there
is a positive correlation between tannins, ﬂavonoids and triter-
penoids content and the inhibition of a-glucosidase. Flavo-
noids inhibit a-glucosidase through hydroxylation bonding
and substitution at b ring (Hardoko et al., 2015). This inhibi-
tion decreases carbohydrate hydrolysis and glucose absorp-
tion, and inhibits carbohydrates metabolism into glucose
(Hardoko et al., 2015).
Additionally, glycemic index (GI) and glycemic load (GL)
have been reported for A. muricata fruit. GI indicates the effect
of the content and type of carbohydrates of a food on blood
glucose content, while GL estimates how much the food will
raise blood glucose level after eating it. GI and GL are consid-
ered low for A. muricata, which agrees with its hypoglycemic
potential (Passos et al., 2015).
4.2.2. Anti-cancer activity
Ethyl acetate extract of A. muricata leaves showed chemopre-
ventive properties on azoxymethane-induced colonic aberrant
crypt foci in rats (Moghadamtousi et al., 2015c). As aceto-
genins, the extract downregulates PCNA and Bcl-2 proteins,
upregulates Bax protein and restores the levels of the antioxi-
dant enzymes. An excessive ROS generation results in the pro-
duction of lipid radicals such as malondialdehyde (MDA), and
an elevated concentration of MDA was observed in patients
suffering from colorectal cancer (Moghadamtousi et al.,
2015c). A. muricata extract treatment reduced MDA formation
in colon tissue, conﬁrming its protective effect against oxida-
tive stress.
4.2.3. Anti-tumorigenic activity
Anti-tumoral activity has been reported for extracts and some
isolated acetogenins of A. muricata. Hamizah et al. (2012)prehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
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Table 4 Pharmacological activities of A. muricata extracts evaluated in vivo.
Activity Plant
part
Solvent Dose Test model and results References
Hypoglycemic Leaf H2O 100 mg/kg p.o. by
25 days
Reduction of blood glucose (4.7 mmol/l) in
diabetes mellitus rats
Adewole and
Caxton-Martins
(2006)
H2O 100 mg/kg p.o. by
25 days
Increase of serum insulin glucose (12.2 lU/ml) in
diabetes mellitus rats
MeOH 100 mg/kg, daily for two
weeks
Reduction of blood glucose (4.22 mmol/l) in
diabetes mellitus rats
Adeyemi et al.
(2009)
H2O 100 mg/kg, daily for
28 days
Reduction of blood glucose (80.75 mg/dl) in
diabetes mellitus rats
Florence et al.
(2014)
Stem
bark
EtOH 100 mg/kg, daily for
14 days
Reduction of blood glucose (187 mg/dl) in
diabetes mellitus rats
Ahalya et al.
(2014)
Anti-cancer Leaf EtOH 100 mg/kg/4 wk Restoration of colon total protein in cycas-
induced colorectal carcinogenesis in rats
Okolie et al.
(2013)
Leaf EtOAc 500 mg/kg/8 wk 72.5% of ACF inhibition in AOM induced
colorectal carcinogenesis in rats
Moghadamtousi
et al. (2015c)
Anti-
tumorigenic
Dried
fruit
H2O:Cet
50%
200 mg/kg/35 wk 32% growth inhibition (weight) of breast tumor
induced by MDA-MB-468 cell in rats
Dai et al. (2011)
Leaf/
Stem
H2O 50 mg/kg/35 days 59.8% growth inhibition of pancreatic tumor
induced by CD18/HPAF cell in rats
Torres et al. (2012)
Leaf EtOH/H2O 30 mg/kg bwt 0% of incidence of initiation and promotion of
tumors induced in mouse skin
Hamizah et al.
(2012)
Anti-diarrhea Leaf MeOH 25 a 200 mg/kg, vo 13.94% of inhibition of activated charcoal transit
in mouse
Salinas et al.
(2011)
Gastroprotective Leaf EtOH 80% 300 mg/kg 92.8% of inhibition of total area of gastric lesion
in rats
Roslida et al.
(2012)
Leaf EtOAc 400 mg/kg Reduction of ulcer index in ethanol-induced
ulcerogenesis in rats
Moghadamtousi
et al. (2014)
Hepato-
protective
Leaf H2O 400 mg/kg twice daily for
7 days:
Reduction of bilirubin level (5.68 lmol/l) in rats
hyperbilirubinemia induced
Arthur et al.
(2012a)
Leaf H2O 50 mg/kg 97% of protection versus hepatotoxicity induced
in rats by CCl4
Arthur et al.
(2012b)
Leaf H2O 100 mg/kg 100% of protection versus hepatotoxicity induced
in rats by acetaminophen
Anti-
inﬂammatory
Leaf H2O 1.5 mg/kg 71.12% reduction of plant edema induced in
mouse model
Poma et al. (2011)
Leaf EtOH 400 mg/kg Reduction of volume (0.47 ml) of carrageenan-
induced paw edema in rats
Sousa and Vieira
(2010)
Anti-nociceptive Leaf EtOH 80% 10 mg/kg op 53.92% prolongation of reaction time of mice
exposed to the hot plate
Roslida et al.
(2012)
Leaf EtOH 80% 300 mg/kg 95.3% inhibition of abdominal writhes of mice
induced by 0.6% acetic acid
Leaf EtOH 80% 100 mg/kg 47.36% of reduction time spent licking on
formalin-induced in mice
Leaf EtOH 400 mg/kg 41.41% inhibition of acetic acid-induced writhing
in mice
Sousa and Vieira
(2010)
Leaf EtOH 400 mg/kg Increase the latency time (13.25 min) in mice
Leaf EtOH 400 mg/kg 45% inhibition of formalin-induced nociception in
mice
Anxiolytic-like
eﬀect
Leaf EtOH 40% 0.5 g/kg, vo: 45% reduction of time reaction in Albino mice/
elevated plus maze
Oviedo et al.
(2009)
Hypotensive Leaf H2O 48.53 mg/kg Reduction of blood pressure (57.7 mm Hg) in rats Nwokocha et al.
(2012)
Wound healing Stem
bark
EtOH 4% in ointment/12 days 88.58% reduction of area of open wound
produced in rats
Padmaa et al.
(2009)
Leaf EtOAc 10% in cream, two
applications a day per
15 days
77% of wound closure in rats Moghadamtousi
et al. (2015b)
NR, Not reported; EtOH, ethanol; H2O, water; MeOH, methanol; EtOAc, ethyl acetate; Cet, cetone; CCl4, carbon tetrachloride; wk, week;
ACF, aberrant crypt foci; AOM, azoxymethane.
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showed greater anti-tumor activity in murine models than cur-
cumin, a known natural chemopreventive. This extract has
shown protective effect in biochemical events and in morpho-
logical changes in induced colorectal carcinogenesis. Aqueous
extract of commercial powder capsules containing leaf and
stem of A. muricata also showed anti-tumorigenic and anti-
metastatic activities on pancreatic tumors in murine models
(Torres et al., 2012). Breast tumor in rats was reduced by treat-
ment for 5 weeks with A. muricata fruit extract (Dai et al.,
2011). The mechanism of action suggests the inhibition of mul-
tiple signaling pathways that regulated metabolism, metastasis,
induction of necrosis and cell cycle arrest (Torres et al., 2012;
Dai et al., 2011), has been shown in cytotoxic mechanism.
Antitumor activity was also reported for two acetogenin iso-
lates of A. muricata (Ko et al., 2011; Wang et al., 2002). Ko
et al. (2011) reported that bullatacin at doses of 400 mg/kg
was able to reduce a tumor induced in rodents 300 times better
than the commercial drug Taxol (paclitaxel). Meanwhile,
annonacin at doses of 10 mg/kg reduced tumor size induced
in murine models comparable to the commercial drugs cis-
platin and adriamycin (Wang et al., 2002). A study by Yang
et al. (2015) demonstrated that crude leaf extract showed more
in vitro inhibition of prostate cancer proliferation and more
effect on tumor growth-inhibition than ﬂavonoid-enriched
extract. This report suggests that the effectivity of crude
extract is probably due to a synergistic interaction between ﬂa-
vonoids and acetogenins.
4.2.4. Hepatoprotective and gastroprotective activities
Arthur et al. (2012a, 2012b) studied the hepatoprotective activ-
ity of the leaf aqueous extract of A. muricata. They reported
that the extract was effective against hyperbilirubinemia or
jaundice with similar effect to silymarin (Silybum marianum).
The extract reduced the harmful effect and preserved the hep-
atic physiological mechanism of the liver damaged by a hepa-
totoxin such as paracetamol (Acetaminophen), a drug widely
used as antipyretic and analgesic, which can cause liver dam-
age if taken in excessive (Arthur et al., 2012b). This study sug-
gests that soursop extract reduces bilirubin levels due the
glucosides present in the extract, which might be converted
into glucuronic acid, conjugating with bilirubin for excretion,
or because the extract active regulators increase the activity
of enzymes, synthesis of transporter, and steps related to
bilirubin clearance pathway (Arthur et al., 2012b).
Ethyl acetate and ethanol extracts from leaf of A. muricata
showed protective gastric effect like omeprazole in ethanol-
induced ulcerogenesis in rats (Moghadamtousi et al., 2014;
Roslida et al., 2012). Antiulcer potential of A. muricata is
probably through its antioxidant compounds that increase
the mucosal nonprotein sulfhydryl group content (Roslida
et al., 2012). The excessive production of gastric acid in
patients with ulcers can reduce the level of gastric wall mucus
(GWM). A. muricata extract caused attenuation in gastric
acidity and retrieved the loss in GWM like proton pump inhi-
bitors drugs as omeprazole but in less proportion. Addition-
ally, the antioxidant effect of A. muricata extract can play
an important role in the gastroprotection. The ROS produce
oxidative damage to the gastric mucosa. A. muricata extract
restores the activity of enzymes such as glutathione (GHS),
catalase (CAT), nitric oxide (NO), superoxide dismutasePlease cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
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(PGE-2) that reduces cellular ROS. Histopathological analy-
sis showed that the extract protects the gastric tissue from
hemorrhagic lesion associated with attenuation of leukocyte
inﬁltration and submucosal edema (Moghadamtousi et al.,
2014).
4.2.5. Anti-inflammatory and anti-nociceptive activities
Anti-inﬂammatory activity similar to the activity presented by
indomethacin, which is a nonsteroidal anti-inﬂammatory, has
been reported (Poma et al., 2011; Sousa and Vieira, 2010).
The antinociceptive effect of ethanolic and hydroalcoholic
extracts of A. muricata has been reported using various chem-
ical and thermal nociceptive models. A. muricata produced
antinociception action of activity in both neurogenic and
inﬂammatory phases (Roslida et al., 2012). Metabolites of
arachidonic acid (called icosanoids) are involved in inﬂamma-
tion process (Poma et al., 2011). These metabolites are pro-
duced via cyclooxygenase and lipoxygenase when a cell is
activated by mechanical trauma, cytokines, growth factors or
other stimuli. It has been proposed that the mechanism of
antinociception may be by inhibition of cyclooxygenase
(COX) and lipoxygenases (LOX) and other inﬂammatory
mediators by ﬂavonoids present in the plant extract (Poma
et al., 2011).
4.2.6. Anxiolytic and anti-stress activities
The anxiolytic and the anti-stress effects were more effective in
the alkaloid fraction than in the crude hydroalcoholic extracts
(Oviedo et al., 2009). It is possible to attribute this bioactivity
to the alkaloid compounds; especially because two of the iso-
lated alkaloids (anonaine and asimilobine) have relaxing activ-
ity. These compounds can inﬂuence the central nervous system
via the 5HT1A receptor. The 5HT1A receptor binds with the
endogenous neurotransmitter serotonin and is involved in
the modulation of emotion (Hasrat et al., 1997a, 1997b). This
bioactivity can validate the reason for the traditional use of A.
muricata as sedative.
4.2.7. Hypotensive activity
Leaf extract of A. muricata caused a dose-dependent reduc-
tion in mean arterial pressure (MAP) in normotensive rats
(Nwokocha et al., 2012). The suggested hypotensive mecha-
nism of action of aqueous extract of A. muricata did not
involve the endothelial or nitric oxide-dependent pathways.
Studies suggested that plant extracts lower blood pressure
through the blockage of calcium ion channel, and this
Ca+ antagonism is further demonstrated by its ability to
relax high K+ induced contractions (Nwokocha et al.,
2012). The hypotensive effect has been attributed to alka-
loids such as coreximine, anomurine, and reticulin, and some
essential oil components such as b-caryophyllene (Nwokocha
et al., 2012).
4.2.8. Wound healing
Bark and leaf extracts showed elevation in wound contraction
compared with wound without treatment (Padmaa et al., 2009;
Moghadamtousi et al., 2015b). Wound healing consists of four
complex phases: coagulation, inﬂammation, proliferation and
maturation. A. muricata accelerates some of these phases. Inprehensive review on its traditional medicinal uses, phytochemicals, pharmaco-
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teins (Hsp70) is important for healing due to their role in cell
proliferation. A. muricata induced upregulation of Hsp70 in
wound tissues. In this phase the inﬂammatory cells produce
cytokines and free radicals that in great quantity can produce
lipid peroxidation in wound. Tissues treated with A. muricata
extracts showed elevated activity of CAT, GPx and SOD that
protect tissue against oxidative damage to accelerate the
wound healing process. Additionally, A. muricata extracts
reduce MDA, the biomarker of lipid peroxidation that can
cause defect in endothelial cells, ﬁbroblast and collagen meta-
bolism necessary for wound healing. During the maturation
phase, the collagen accumulation and ﬁbroblast proliferation
occurred. A. muricata extracts elevated the deposition of colla-
gen ﬁbers in the wound as observed in histological analysis
(Moghadamtousi et al., 2015c).
4.3. Clinical studies
Ethanolic extracts of A. muricata leaves have been clinically
evaluated in relation to their hypoglycemic activity. Arroyo
et al. (2009) conducted a randomized, parallel grouped, double
blind phase II clinical trial, in patients with type 2 diabetes
mellitus. Groups of patients were given 1, 2 or 3 capsules of
ethanol extract from A. muricata leaves (180 mg) plus 5 mg
of glibenclamide for 30 days, and another group only received
glibenclamide. The results of this study showed a decrease in
the blood glucose or glycemia level in patients receiving extract
of A. muricata compared to patients who did not receive it.
Side effects were reported in 11% of patients (ﬁve patients)
receiving A. muricata extract. Two of them mentioned burning
pain in epigastrium, one was associated with nausea, and the
remaining three reported nausea (Arroyo et al., 2009). Com-
pounds responsible for the hypoglycemic activity found in
the A. muricata leaf extracts could be ﬂavonoids and alkaloids,
which are present in the leaves and the fruit (Table 2).
Additional to the clinical study described above, two cases
of anticancer evaluations have been reported (Hansra et al.,
2014; Yap, 2013). In one of them, tumor markers showed that
a breast cancer patient has been stable and had no side effectsTable 5 Neurotoxicity and mutagenicity of acetogenins and alkalo
Activity Compound Dose Test model and resu
Mutagenicity Annonacin
Squamocin
1000 lg/plate: No mutagenic accor
Neurotoxicity Coreximine
Reticuline
Annonacin
EC50: 13 lM
EC50: 304 lM
EC50: 0.018 lM
Viability reduction o
Annonacin 50 nM Induced concentrati
reduction brain ATP
Solamin
Annonacin
Annonacinone
Isoannonacin
EC50: 1210 nM
EC50: 60.8 nM
EC50: 189.7 nM
EC50: 121.3 nM
Viability reduction o
Annonacin 3800 and
7600 lg/kg for
28 days
Reduction brain AT
the brain stem and
Annonacin 7600 lg/kg/day
for 28 days
Neurodegeneration
EC50: Median effective concentration
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sisted in taking 227 gm of leaves decoction of A. muricata
(10–12 dry leaves in water for 5–7 min) daily and Capecitabina
(2500 mg PO) 2 weeks on one week off (Hansra et al., 2014).
The other case of study involves the disappearance of the
malignancy with substantial regression of colon tumor cells
in a patient who combined lifestyle modiﬁcations with the
intake of some herbal extracts and nutraceuticals. The therapy
included the daily ingestion of 5 g of powered leaf and seed of
A. muricata extract (Yap, 2013).
5. Toxicology
Considerable information, both formal and informal, is avail-
able on the relation of the consumption of A. muricata with the
appearance of an atypical Parkinson’s disease (Caparros-
Lefevre et al., 2002; Lannuzel et al., 2006). The toxicity
reported for the extracts is variable depending on the plant
part used, and the solvent employed (Table 5).
5.1. Acute toxicity
Aqueous extracts showed a LD50 > 5 g/kg, while methanolic
and ethanolic extracts of leaves, ﬂowers and pulp had a
LD50 of > 2 g/kg (Sousa and Vieira, 2010), which are
considered non-toxic according to the guidelines of OECD
(http://www.oecd.org/chemicalsafety/testing/oecdguidelines-
forthetestingofchemicals.ht). The median lethal dose of aque-
ous extract of leaves is above the expected consumption for a
human, which is about 211 mg/kg per day, considering that an
average person consumes one cup of tea three times per day
(Arthur et al., 2011). Therefore, for a human to reach the lethal
dose of consumption of soursop leaf infusion would require
consuming more than 71 cups of tea a day. For toxicity in
organs, Arthur et al. (2011) reported that doses greater than
5 g/kg of aqueous extract might cause kidney damage, unlike
the 1 g/kg dose that showed hypoglycemic and hyperlipidemia
properties. The most toxic extracts that have been reported are
methanol extracts of pericarp, fruit pulp or seed (Boyom et al.,
2011). A. muricata pulp consumed for 28 days showed noids of A. muricata.
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24 A.V. Coria-Te´llez et al.effect in blood hematology and serum biochemistry (Syahida
et al., 2012). A study that evaluated the toxicity of crude leaf
extract and its ﬂavonoid and acetogenins enriched extracts
shows that acetogenins-enriched extract was more toxic than
others (Yang et al., 2015). This study suggested that whole
extract could pose similar bioactive properties of its fractions
or isolated constituents, but without their toxicity.
5.2. Neurotoxicology
The association of the consumption of fruit and homemade
preparations of A. muricata with the appearance of atypical
Parkinsonism in the Caribbean Island of Guadeloupe is based
on a case study published in 1999 (Caparros-Lefevre et al.,
2002). This association has also been reported in New Caledo-
nia and Caribbean patients living in London (Shaw and
Ho¨glinger, 2008). From these studies, assessment of the neuro-
toxic effect of the main bioactive compounds of A. muricata
alkaloids and acetogenins was initiated. It was evident that
some of the isolated compounds induce neurotoxicity and neu-
rodegenerative diseases in murine models (Table 5).
The reticuline and coreximine alkaloids and solamin,
annonacinone, isoannonacinone and annonacin acetogenins
were shown to be toxic to dopaminergic cells by impairing
energy production (Escobar-Khondiker et al., 2007; Hoˆllerhage
et al., 2009; Lannuzel et al., 2002, 2003, 2006). Annonacin toxi-
city was greater than the toxicity of the pesticide rotenone, which
was used as a positive control. Champy et al. (2005) and
Lannuzel et al. (2006) reported that in murine models annonacin
enters the brain parenchyma, decreases ATP levels and induces
neurodegeneration in the basal ganglia. According to these
authors, this neurodegeneration induced no change in the behav-
ior or locomotor activity in rodents.
Regarding the neurotoxicity, seven acetogenins have been
evaluated using mesencephalic dopaminergic neurons, rat stri-
atal neurons cells and laboratory rats (Table 5). Champy et al.
(2005) reported that annonacin and reticuline, which are the
most abundant acetogenin and alkaloid in A. muricata, respec-
tively, are neurotoxic. Annonacin is about 1000 times more
toxic for neuronal cell cultures than reticuline, and 100 times
more potent than 1-methyl-4-phenylpyridinium (MPP), a
known neurotoxin that causes Parkinsonism in humans and
animal models. This study was conducted by administering
isolated annonacin to laboratory rats intravenously. The
amount administered to rats was determined by estimating
the amount of annonacin a human would consume by ingest-
ing fruit or canned nectar daily for one year. Neurotoxicity
studies of annonacin suggest that there is a need for a long
exposure to this molecule to observe the effect in murine mod-
els, while pharmacokinetic studies estimated low bioavailabil-
ity of this compound. In this regard, AVIS (l’Agence
Francaise de Se´curite´ des Aliments) in 2010 issued a statement
which concluded that on the basis of available experimental
data, it is not possible to say that cases of atypical parkinso-
nian syndromes observed in Guadeloupe are linked to con-
sumption of species belonging to Annonaceae family.
6. Conclusions
A. muricata is widely used in traditional medicine to treat illness such
as diarrhea, dysentery and fever, pain, respiratory and skin illness,
internal and external parasites, bacterial infections, hypertension,Please cite this article in press as: Coria-Te´llez, A.V. et al., Annona muricata: A com
logical activities, mechanisms of action and toxicityAnnona muricata –>. Arabian Jinﬂammation, diabetes and cancer. Decoctions of bark, root, seed or
leaf are the most widely used preparations. In vitro and in vivo studies
support the majority of the traditional uses but lack clinical validation.
Among the traditional uses that have not shown scientiﬁc validation
yet are the effectivity in treating respiratory tract, heart and kidney
affections, treatment to animal bites and stings, and obesity
treatments.
More than 200 phytochemicals have been identiﬁed in this plant,
mainly acetogenins, alkaloids and phelos. These phytochemicals have
shown pharmacological activities such as antimicrobial, antiproto-
zoan, antioxidant, insecticide, larvicide, selective cytotoxicity to
tumoral cells, anxiolytic, anti-stress, anti-ulceric, wound healing,
anti-icteric, hepatoprotective, and hypoglycemic. New phytochemicals
are been identiﬁed in soursop.
Mechanisms of action of the plant extracts and phytochemicals
have been proposed. Cytotoxicity implies the disruption of mitochon-
drial membrane to arrest cells in G0/G1 phase, and the induction of
apoptosis, the inhibition of multiple signaling pathways that regulate
metabolism, induction of metastasis and necrosis of cancer cells.
Mechanism of action of antioxidant activity is by hydrogen donation,
while antimicrobial action is because of some phytochemicals having
the ability to bind with DNA and inhibiting RNA synthesis and by
glycosidase inhibition lacking cytoplasmatic membrane function.
Mechanisms of action of antinociception may be by inhibition of
cyclooxygenase and lipoxygenase enzymes and other inﬂammatory
mediators. Hypotensive mechanism is thought to be through the
blockage of calcium ion channel. Mechanisms of action of other bioac-
tivities have not been completely elucidated, such as anxiolytic, anti-
stress and hypoglycemic activities.
Some phytochemicals, such as acetogenins, have shown neurotox-
icity in vitro and in vivo studies. More research is needed to quantify
the amount of neurotoxic compounds and to determine the level of
human exposure. Metabolic studies are also necessary to determine
whether digestive processes decrease or increase bioactivity and/or
neurotoxicity of the active compounds. These studies have been
extended to whole extract used in medicinal treatments.References
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